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Abstract 
Depression is common in those with HIV and is associated with lower quality of life, 
reduced adherence to medication, worse disease progression and higher risk of 
transmission to other. The majority of HIV-infected youth live in Southern Africa, but 
research predominantly focuses on adults from Western countries, with limited 
generalisability across these populations. This review aimed to identify and synthesise 
research on the risk factors for depression in HIV-infected youth in Southern Africa, 
and to summarise the available evidence on psychosocial interventions to reduce 
depression. Papers from 2004–2017 were searched using Embase, PsycNet, PubMed 
and Scopus. Six studies met inclusion criteria for assessing risk factors, but only three 
focused exclusively on HIV-infected youth (n=1,113; age 9–19 years). Two studies met 
inclusion criteria for assessing psychosocial interventions, but only one focused 
exclusively on HIV-infected youth (n=33; age 10–13 years). Overall, study quality was 
low and methodology was heterogeneous, limiting comparability and conclusions. The 
findings indicate some evidence for demographic factors; social and community support 
factors; reduced immunosuppression; past traumas/stressors; and psychosocial factors 
as potential risk factors for depression. Neither of the intervention studies successfully 
reduced depression, demonstrating a need for low-cost, large scale interventions to be 
developed and trialled. HIV status should be acknowledged as an important factor in 
future psychosocial research in Southern Africa. 
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their support with paper screening and quality assessment. 
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Introduction 
It has been consistently demonstrated that rates of depression are considerably 
higher in HIV-infected adults than in HIV-uninfected adults (Arseniou, Arvaniti, & 
Samakouri, 2014; Breuer, Myer, Struthers, & Joska, 2011; Freeman, Nkomo, Kafaar, & 
Kelly, 2008). This finding has been replicated amongst HIV-infected youth aged as 
young as nine (Elkington et al., 2010; Mellins et al., 2009; Pao et al., 2000). 
Antiretroviral treatment (ART) for HIV made huge advances in the mid-nineties with 
the advent of ‘triple combination’ ART (Palmisano & Vella, 2011). This treatment was 
rolled out globally, but the drugs only became publically available in South Africa in 
2004 (Simelela & Venter, 2014). The effectiveness of ART is now such that HIV is 
largely viewed as a manageable, chronic condition. Despite this, rates of depression 
have been found to be higher in youth with HIV than youth with other chronic, life-
threatening conditions (Pao et al., 2000). 
The association between HIV and depression is bidirectional; while HIV is 
acknowledged as a risk factor for depression, the presence of depression in those with 
HIV has been shown to have a serious impact on health-related outcomes. In HIV-
infected youth, depression has been associated with decreased adherence to ART (Agwu 
& Fairlie, 2013; Murphy, Wilson, Durako, Muenz, & Belzer, 2001; Naar-King et al., 
2006) and higher risk behaviour (Donenberg & Pao, 2005), thus posing a higher risk of 
transmission to others. There are further serious consequences if depression continues 
into adulthood; depression in HIV-infected adults is associated with poorer quality of 
life (Adewuya et al., 2008; Andrinopoulos et al., 2011; Selvaraj, Ross, Unnikrishnan, & 
Hegde, 2013), faster disease progression (Ironson et al., 2015; Kopnisky, Stoff, & 
Rausch, 2004; Leserman, 2003) and, according to some studies, earlier death (Cook et 
al., 2004; Kopnisky et al., 2004). Early identification and treatment of depression in 
HIV-infected youth therefore has the potential to improve morbidity and quality of life 
and reduce transmission to others and mortality. 
Southern Africa constitutes the nine countries with the highest adult (aged 15–
49) HIV prevalence globally, ranging from 10.3% in Malawi to 27.4% in Swaziland 
(UNAIDS, 2014). Prevalence data for HIV in youths is less forthcoming, but more than 
half of all HIV-infected children (aged 0–14) live across these nine countries (UNAIDS, 
2013). Despite this region having the highest global prevalence of HIV, a 2011 
systematic review of interventions for depression in HIV-infected individuals found that 
just one of the 90 included studies originated from Southern Africa, with the vast 
majority of studies (n=81) based in Europe and North America (Sherr, Clucas, Harding, 
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Sibley, & Catalan, 2011). There are several factors that limit the applicability of these 
findings to youth in Southern Africa. For example, most European/American studies 
recruited adult male participants with a mean age of 30–40, reflecting the focus on 
intravenous or homosexual HIV transmission (Sherr et al., 2011). Interventions are 
therefore unlikely to be developmentally appropriate or take account of relevant 
systemic contextual differences, such as living with caregivers and attending school. 
Factors associated with depression—and relevant to treatment—are also likely to differ 
across these populations. For example, transmission is most commonly vertical in 
children and via heterosexual contact in adolescents (UNAIDS, 2014; Breuer et al. 
2011). This has implications for adjustment to HIV and introduces other factors that 
may be important, such as having other family members with HIV. In addition, females 
are disproportionally affected by HIV in Southern Africa; females aged 15–19 in South 
Africa are eight times more likely to be HIV-infected than males of the same age (South 
African National AIDS Council Trust, 2015), indicating that gender-related factors may 
be of importance. Finally, there are several cultural, political and societal differences 
between Western countries and Southern Africa that have implications for both risk 
factors for depression and for delivery of interventions. Research directly from Southern 
Africa is essential for ensuring findings are relevant to Southern African youth and to 
ensure interventions are viable given resources and the local context. Understanding 
specific factors associated with depression in this population is important for tailoring 
interventions for reducing and preventing depression. Previous reviews have identified 
several potential risk factors for depression in HIV-infected populations, including: 
biological HIV factors; gender; homelessness; lack of social support; psychosocial 
factors; history or comorbidity of psychiatric illness; and the perinatal period in HIV-
infected women (Arseniou, Arvaniti, & Samakouri, 2014; Nanni, Caruso, Mitchell, 
Meggiolaro, & Grassi, 2014). However, these reviews were unsystematic—lacking 
information about the process of study selection, overall study characteristics or the 
process of data synthesis, as well as lacking critical information about participant 
characteristics, such as country of origin or age. Breuer et al. (2011) reviewed research 
in adults in sub-Saharan Africa and identified stage of illness; poor social support; 
presence of life stressors; and stigma as potential risk factors for depression in HIV-
infected, but, again, it is unclear to what degree these findings would generalise to HIV-
infected youth in the high prevalence region of Southern Africa.  
Developing effective treatments for depression in people living with HIV has 
far-reaching consequences for improved quality of life, physical health and reduced 
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transmission to others. Psychological interventions are more consistently effective at 
treating depression in HIV-infected participants than other interventions, including 
psychotropic drugs (Sherr et al., 2011) and eliminate potential medical interactions with 
ART (Cruess et al., 2003), providing a strong rationale for developing effective 
psychological support for HIV-infected youth. Most HIV-infected youth globally live in 
Southern Africa, yet current understanding of depression in those living with HIV is 
based predominantly on adult samples from resource-rich settings. This review aims to 
synthesise existing research about depression in HIV-infected youth in Southern Africa 
by answering the follow questions: 
1. What factors are associated with depression in HIV-infected youth living in 
Southern Africa? 
2. What does the research tell us about interventions that have been 
implemented in Southern Africa to reduce depression in HIV-infected youth? 
 
Method 
A systematic review was conducted according to PRISMA guidelines (Moher, 
Liberati, Tetzlaff, & Altman, 2009). 
 
Search Strategy 
Literature searches were carried out in August 2016 using search terms 
developed in collaboration with a University librarian. Embase, PsycNet, PubMed and 
Scopus were searched. See Table 1 for Scopus search strategy. Search strategies for the 
other databases were similar, but ‘all fields’ were searched rather than limiting to ‘title, 
abstract and keywords’. In addition, database filters were used to restrict the age of 
participants, in place of using search terms relating to children and adolescents. For the 
purpose of this review, Southern Africa comprises the following nine countries: 
Swaziland, Lesotho, Botswana,  South Africa, Namibia, Zimbabwe, Zambia, 
Mozambique and Malawi. These countries have the highest HIV prevalence globally. To 
identify grey literature, reference lists of included articles were hand-searched and the 
first 100 references of Google Scholar were searched using the search terms. Database 
searches were repeated in April 2017 to check for up-to-date studies; 61 new, unique 
abstracts were identified.  
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Eligibility Criteria 
Studies that used quantitative methodologies to explore the association between 
depression and other variables in HIV-infected youth were identified. Intervention 
studies for depression in HIV-infected youth were also identified. Although the primary 
focus of this review was youth aged <18 years, studies were permitted to include 
participants as old as 19 years. This decision was taken because demographic data often 
groups adolescents into 15–19-year-olds (e.g. UNAIDS, 2013) and in Southern Africa it 
is not uncommon for youth to be aged 19 when completing grade 12 of school (Cosser 
& du Toit, 2002).  
To be included, a study had to: (a) include participants younger than 18 years; 
(b) include no participants older than 19 (unless data was reported separately for those 
≤19 years); (c) report participants’ HIV/AIDS status; (d) recruit participants exclusively 
from Southern Africa; (e) report a measure of depression (either psychiatric interview or 
validated mood scale); (f) explore variables associated with/predictive of depression 
AND/OR evaluate impact of a non-medication intervention on depression; (g) be 
published in English or Afrikaans; (h) be published since 2004. 
ART has impacted prognosis and illness trajectory and may have introduced new 
factors associated with depression, such as medication routines. As this was not rolled 
out to some Southern African countries (e.g. South Africa, Malawi) until 2004, this was 
chosen as a publication date cut-off. 
 
Table 1. Scopus search strategy 
Field code Search terms used 
Title-Abstract-
Keywords 
depress* OR “affective disorder*” OR “adjustment disorder*” OR 









botswana* OR batswana OR swazi* OR zimbabwe* OR namibia* OR 
mozambi* OR lesotho OR basotho OR "south africa*" OR malawi* 




child* OR teen* OR young OR pediatric OR paediatric OR adolescen* 
OR youth* OR juvenile* OR infant* 
 AND 
Database filters applied Publication year > 2003 
Language: English or Afrikaans 
Document type: article, article in press, conference paper 
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Selection of Studies 
Articles returned from database searches were screened for duplicates (CH). 
Fifty percent of titles and abstracts returned were screened by a second independent 
rater (NS). Inter-rater agreement was ‘moderate’ (Landis & Koch, 1977) at 82% (κ = 
0.48). To improve consistency in abstract screening, the following rating guidelines 
were developed:  
1. Abstracts were excluded if: (a) there was no mention of HIV, or if the only 
reference was in the context of ‘area of high HIV prevalence’; (b) 
participants were referred to as ‘adults’; or (c) participants were clearly 
recruited from outside of Southern Africa. 
2. To be included, abstracts needed to clearly demonstrate at least two of the 
following three criteria: (a) inclusion of participants <18 years; (b) 
participants with HIV; (c) a measure of depression mentioned.  
Previous disagreements were discussed and resolved using these guidelines. The 
remaining 50% were then screened independently by the same raters, yielding an 
‘almost perfect’ agreement (Landis & Koch, 1977) of 94% (κ = 0.85). Again, conflicts 
were discussed and resolved. 
Full texts of included articles were then screened by two raters (CH and RR) 
using the study eligibility criteria. Where studies comprised both eligible samples (≤19 
years) and non-eligible participants (>19 years), authors were contacted and asked for 
the data pertaining to those ≤19 years. Of the authors contacted (n=5), one provided the 
data requested. 
 
Quality Assessment and Risk of Bias 
Quality assessment tools were developed for each of the review questions, 
which addressed risk of bias within studies. A 16-point quality assessment tool was 
developed for cross-sectional and longitudinal studies, informed by previously used 
tools (Herzog et al., 2013; Matcham, Rayner, Steer, & Hotopf, 2013). A second 17-point 
tool was developed for the assessment of intervention studies, which incorporated 
additional elements for intervention studies (Downs & Black, 1998). See Appendix A 
for both quality assessment tools. 
Two independent raters (CH and HW) assessed the quality of papers using the 
tools. Quality of papers was assessed according to the questions posed in this review. 
Discrepancies were minimal and were resolved by a third rater (ML). 
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Data Extraction and Synthesis 
The small number of eligible studies and heterogeneity of risk factors studied 
precluded a meta-analysis. Data extraction was carried out using a purpose-designed 
form. Where data relevant to the review questions were not reported separately, authors 
were contacted (n=3); none provided the data. Data was presented using narrative 
synthesis for: (a) risk factors associated with depression; and (b) effectiveness of 
interventions for reducing depression. For synthesis of risk variables associated with 





Figure 1. PRISMA flowchart of study selection (Moher et al., 2009). 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
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Results 
A total of six studies met the inclusion criteria for examining risk factors for 
depression in HIV-infected youth in Southern Africa. A further two studies met the 
inclusion criteria for examining effectiveness of interventions for reducing depression in 
HIV-infected youth in Southern Africa. See Figure 1 for flow chart of study selection. 
 
Risk Factors Associated with Depression 
Study characteristics and quality. Six studies were included, comprising a 
total of 1,271 HIV-infected youth (aged 4–19 years). Of the six studies, three comprised 
HIV-infected participants exclusively (Bhana et al., 2016; Kim et al., 2015; Woollett, 
Cluver, Bandeira, & Brahmbhatt, 2017). Participants in Målqvist, Clarke, Matsebula, 
Bergman and Tomlinson’s (2016) study comprised both adults and adolescents (age 
≥14), only some of whom were HIV-infected (n=412). However, the authors provided 
their dataset when contacted, allowing separate analysis for eligible participants (n=31) 
and therefore inclusion in this review. The remaining two papers (Sherr, Croome, 
Clucas, & Brown, 2014; Skeen, Macedo, Tomlinson, Hensels, & Sherr, 2016) contained 
exclusively child and adolescent participants (ages 4–19), but data was not consistently 
reported separately for HIV-infected participants. Authors were contacted for this data, 
but this was not provided, strongly limiting the conclusions that can be drawn from 
these studies. As a result, analysis is largely based on a sample of 1,113 HIV-infected 
youth aged 9–19 years.  
None of the included studies provided justification or power analyses for their 
sample sizes, but the three studies that focused solely on HIV-infected youth provided 
sample sizes of 177 (Bhana et al., 2016); 343 (Woollett et al., 2017); and 562 (Kim et 
al., 2015). These studies also recruited from specialist HIV clinics using convenience 
sampling. While this provides a feasible recruitment method for researchers, and is an 
effective way of verifying the HIV status of participants, convenience sampling is 
associated with a higher risk of bias than consecutive or random sampling (Schuster & 
Powers, 2005). In addition, recruiting from HIV clinics is likely to exclude youth who 
have not undergone testing, choose not to use HIV services, or are unable to do so. The 
remaining three studies used the more robust method of consecutive sampling, but 
relied on self-report of HIV status (Målqvist et al., 2016; Sherr et al., 2014; Skeen et al., 
2016) and did not report data separately for HIV-infected participants. Although 
Målqvist et al. (2016) provided their dataset on request, only 31 participants were 
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eligible for inclusion in this review reducing the power of the analysis and 
generalisability of the results. 
Studies recruited from South Africa (Bhana et al., 2016; Sherr et al., 2014; 
Skeen et al., 2016; Woollett et al., 2017); Malawi (Kim et al., 2015; Skeen et al., 2016); 
and Swaziland (Målqvist et al., 2016). Two studies focused on sub-populations of HIV-
infected youths: perinatally-infected youths (excluding those infected via horizontal 
transmission; Bhana et al., 2016) and pregnant females (Målqvist et al., 2016).  
Only one study used a clinical interview (Child Depression Rating Scale-
Revised; CDRS-R) to measure depression (Kim et al., 2015). While clinical interviews 
are deemed more methodologically rigorous than screening tools, clinical interviews too 
have their limitations. As outlined by Kim et al. (2014), although the CDSR-R has 
demonstrated excellent psychometrics in Europe, America and Asia, the lack of child 
mental health research and public sector resource in Southern Africa means there is a 
lack of validation for the CDRS-R in these countries. This is of particular significance 
given the cultural adaptation of measures that is required (Kim et al. 2014). Kim et al. 
(2015) used the Beck Depression Inventory-II (BDI-II) screening tool in addition to 
clinical interview. The remaining five studies used screening tools only: one used the 
Edinburgh Postnatal Depression Scale (EPDS; Målqvist et al., 2016) and the other four 
used the Child Depression Inventory Short Form (CDI-S; Bhana et al., 2016; Sherr et 
al., 2014; Skeen et al., 2016; Woollett et al., 2017). The BDI-II and EDPS have both 
been validated for use in Southern Africa and psychometrics are reported (Chibanda et 
al., 2010; Kim et al., 2014). Although the CDI-S has been used in Southern Africa, it 
has not been adequately validated; whilst Snider and Dawes (2006) addressed the 
wording of items, no psychometrics were provided for Southern African populations. 
Studies mostly assessed risk factors for higher depressive symptoms (by use of total 
score on screening tools) rather than presence of clinical depression (Bhana et al., 2016; 
Kim et al., 2015; Sherr et al., 2014; Skeen et al., 2016; Woollett et al., 2017). Woollett et 
al. (2017) conducted a second analysis using presence of >50% of symptoms as an 
outcome (defined by the authors as scoring one or two, on five or more items), which 
the authors classified an increased risk of depression. Målqvist et al. (2016) used a cut-
off of ≥13 on the EPDS to compare depressed and non-depressed participants.  
There was considerable heterogeneity in the variables measured, as well as 
method of measurement, limiting comparability across studies. Målqvist et al. (2016) 
focused solely on demographic characteristics of participants in relation to depression. 
Kim et al. (2015) additionally measured psychosocial variables, but no description of 
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the questionnaires used was provided. The remaining papers measured more complex 
variables in addition to demographics and all used a combination of measurement scales 
validated for use in Southern Africa and tools not validated, but described or available 
to the reader (see Table 3).  
Overall, quality of included studies was generally poor with total quality 
assessment scores ranging from 3–8 across the six studies (possible range 0–16). Kim et 
al.’s (2015) study was rated as the most methodologically robust, with a large sample 
size, clinically-verified HIV status and use of clinical interview to assess depression. 
Despite this, reporting of their analyses and results was unclear, making it difficult to 
draw confident conclusions. In addition, description of questionnaires used to measure 
risk factors was poor.  
 
Demographic factors. 
Gender. Two studies assessed the association between gender and depression in 
HIV-infected participants. Being female was associated with higher depressive 
symptoms on both the BDI-II (p=0.002; Kim et al., 2015) and CDI-S (p<.001; Woollett 
et al., 2017). However, gender was not significantly associated with depression when 
determined using clinical interview (Kim et al., 2015), nor when defined as 
experiencing >50% of symptoms on the CDI-S, although this approached significance 
(RR=1.69, p=.06; Woollett et al. 2017). Although Bhana et al. (2016) controlled for 
gender in their analysis, they did not report the direct effect of gender on depression.  
Age. Two studies measured the association between age and depression, with 
one finding evidence of an association with older age. Kim et al. (2015) included 
participants aged 12–18 years and found depression to be associated with older age 
when using cut-off on the CDRS-R (p=.004). When measuring depressive symptoms 
using the BDI-II there was no direct effect of age; however, there were significant 
interactions between age and satisfaction with physical appearance, and age and height-
for-age z-score. More specifically, older participants who were more dissatisfied with 
their appearance (p=.03), or who had a lower height-for-age z-score (p=.007) had higher 
BDI-II scores. Woollett et al. (2017) included participants aged 13–19 years and found 
no association between age and CDI-S score or risk of being symptomatic. Bhana et al. 
(2016) controlled for age in their analysis, but no direct analysis of age was on CDI-S 
score was reported. It was not possible to analyse the association between depression 
and age using Målqvist et al.’s (2016) dataset, as the age range of eligible participants 
was too small at 16–19 years. 
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Ethnicity. Woollett et al. (2017) was the only study to report measuring ethnicity 
as a demographic variable. This was not reported as a significant variable in relation to 
depression. 
Schooling. Two studies measured schooling variables, with contrasting findings. 
While Kim et al. (2015) found fewer years of schooling (categorised by grade) to be 
associated with both higher BDI-II score (p=.0005) and clinical depression using the 
CDRS-R (p=.005), Woollett et al. (2017) found that neither current grade, nor highest 
grade achieved were associated with CDI-S score or risk of being symptomatic. Having 
failed a school term/class was also associated with higher BDI-II score (p=.01 adjusted; 
Kim et al., 2015). 
Household income. Three studies measured household income, with no 
association found with depression. Variables measured were: presence of a job or 
pension (Bhana et al., 2016), estimated combined income (Kim et al., 2015) and 
caregiver receipt of grants for children (Bhana et al., 2016; Woollett et al., 2017).  
Caregiver demographics. Two studies considered a range of caregiver variables 
in relation to depression in youth. Only education of the primary caregiver was 
associated with depressive symptoms, with lower education (defined as eighth grade or 
less) predicting higher CDI-S scores (p=.01; Bhana et al., 2016). Non-significant 
variables were caregiver employment, caregiver depression (measured using screening 
tools), caregiver HIV status (Bhana et al., 2016); primary caregiver type (i.e. single 
parent; both parents; aunt/uncle; grandparent/other); maternal employment status or 
death; and whether there had been a change in caregiver (Kim et al., 2015). 
Food security. Three studies looked at measures of food security, with some 
evidence of an association between less food security and depression. Woollett et al. 
(2017) found that more ‘days hungry’ was significantly associated with higher CDI-S 
score (p<.001), but this was not a significant predictor of experiencing >50% of 
symptoms. Bhana et al. (2016) found higher CDI-S score was associated with less food 
security (p=.029), although this association did not remain significant after controlling 
for age, gender and study indicator. Analysis of eligible participants (n=28) from 
Målqvist et al.’s (2016) dataset found that, in contrast to the overall dataset, there was 
no significant association between depression and their three measures of food security 
(see Appendix B). 
Other household variables. A range of other household variables were 
considered across four studies, with most found to have no association with depression. 
Bhana et al. (2016) found higher CDI-S scores were associated with higher household 
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density (p=.041), although this did not remain significant when controlling for age, 
gender and study indicator. Woollett et al. (2017) found that youth not looking after a 
sick person in the home was significantly associated with higher depression score 
(p=.04). This was not a significant predictor for experiencing >50% of symptoms. 
Analysis of Målqvist et al.’s (2016) dataset demonstrated a significant association 
between being a homeowner/living with parents (rather than renting) and depression 
(p=.047); whilst this replicated findings from the overall dataset, the eligible sample 
was very small (n=22), with only one participant owning their home. There was also a 
trend towards an association between water source and depression (n=30), with those 
sourcing household water from surface more likely to experience depression than those 
sourcing water from communal taps or on-site taps (p=.058); this association was not 
found in the overall dataset. Sharing a toilet was not found to be associated with 
presence of depression in HIV-infected participants aged ≤19 (n=23), although this was 
found to be significant in the overall sample. 
Other variables not found to be associated with depression include whether the 
young person’s caregiver is living in their own home (Bhana et al., 2016); location of 
home; and travel time between home and clinic (Kim et al., 2015); household 
composition; formal or informal housing; and looking after younger siblings at home 
(Woollett et al., 2017). 
 
Social and community support.  
Disclosure. Two studies looked at disclosure in relation to depression, with 
some mixed findings. Kim et al. (2015) found that participants who were aware of their 
HIV status and had disclosed it to others had lower BDI-II scores than those who had 
not disclosed to others, or who were not aware of their HIV status (p=.02). While 
Woollett et al. (2017) found that participants who knew their HIV status had 
significantly lower CDI-S scores than those who did not know (p<.001), they found no 
association between disclosure of their status to others (27% of the sample) and 
depression. 
Other social and community variables. Several social and community variables 
were found to be significantly associated with depression in HIV-infected participants 
across three studies. Bhana et al. (2016) measured caregiver supervision with youth-
rated and caregiver-rated questionnaires addressing rules, how caregivers keep track of 
their child’s whereabouts, and how often children are left in charge of the home. Lower 
youth-rated caregiver supervision was associated with higher depression (p=.01), as was 
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lower likelihood of youths seeking social support (p=.003). Both associations remained 
significant when controlling for age and gender (p=.012 and p=.002 respectively).  
Not having a safe place in the community was significantly associated with 
experiencing >50% of symptoms on the CDI-S (p<.001; Woollett et al. 2017). 
Surprisingly, youth who reported receiving praise at home; getting the same things as 
other children in the home; and feeling like they belonged in the family they were being 
raised in experienced higher CDI-S scores than those who did not (all p<.001; Woollett 
et al., 2017). Kim et al. (2015) asked participants if they had an experience of being in a 
romantic relationship that did not involve sex. Those with a current or past 
boyfriend/girlfriend had higher BDI-II scores than those who had never had a 
boyfriend/girlfriend (p=.002).  
 
Health variables.  Several health variables were assessed in relation to 
depression by two studies. Immunosuppression classification (based on CD4) was the 
only significant variable found, with more severe classification predicting higher BDI-II 
scores (p=.0009), but not depression according to the CDRS-R (Kim et al., 2015). All 
other bio-clinical parameters assessed by Kim et al. (2015) were not significantly 
associated with depression. This included: ART use (93.6% of the sample were on 
ART); efavirenz-based regimen; second-line ART; history of tuberculosis; most recent 
CD4 count; current nutritional status; alcohol use and hospital admission in the past 
year. Woollett et al. (2017) also found that history of tuberculosis and being hospitalised 
were not associated with depression. 
 
Past trauma/stressors. 
Violence and abuse. Two studies looked at measures of violence in relation to 
depression, with mixed findings. While Kim et al. (2015) found no association between 
depression and experience of forced sex, physical abuse or witnessing physical abuse in 
the home, Woollett et al. (2017) found experience of forced sex was significantly 
associated with relative risk of experiencing >50% of CDI-S symptoms (p=.02). 
Furthermore, specific items from measures developed for use in South Africa were 
analysed as predictors and it was found that history of being inappropriately touched 
(p=.01), being hit (p<.001) and feeling unsafe at home (p<.001) were all associated with 
higher CDI-S score, as well as relative risk of experiencing >50% of symptoms (p=.01; 
p=.02 and p<.001 respectively). Peer violence inside and outside of school was also 
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significant in both the bivariate analyses (p=.01) and relative risk analysis (p=.04). 
Having witnessed somebody being stabbed or shot was not found to be associated with 
depression.  
Bereavement. Two studies assessed bereavement as a variable, with 
contradictory findings. Kim et al. (2015) found that a death in the family/household was 
related to higher BDI-II score (p=.01), whilst Woollett et al. (2017) found that neither a 
significant bereavement, nor orphanhood status, were not associated with depression.  
Bullying. Only one study looked at the relationship between depression and 
bullying (Kim et al., 2015). Being bullied for taking medication was found to be 
associated with depression when measured by both the BDI-II and CDRS-R (both 
p<.0001). Being bullied for appearance was not found to be related to depression. 
 
Psychosocial factors. Three studies looked at varied psychosocial factors in 
relation to depression. Woollett et al. (2017) found that suicidality (p<.001); feeling 
unable to one’s their future (p=.04) and not having dreams for one’s future (p<.001) 
were all relative risks for experiencing >50% of symptoms on the CDI-S. These 
variables were also associated with overall CDI-S score, as was higher score on a 
measure of anxiety (all p<.001). Higher score on the Child PTSD Checklist, was not 
significantly associated with depression. 
Bhana et al. (2016) found lower self-concept (as measured using a scale 
validated for use in Southern Africa) was associated with higher score on the CDI-S 
(p<.001), as was higher internal stigma (p=.027). Two of the ten coping styles measured 
by the Kidcope were found to be associated higher CDI-S score: social withdrawal 
(p=.022) and resignation (p=.036), although this was only assessed in the pilot-study 
participants (n=66). 
Kim et al. (2015) found that satisfaction with appearance was not independently 
associated with depression, but there was an interaction effect with age, as previously 
described.  
 
Potential Treatments for Depression 
Study characteristics and quality. Only two studies identified tested 
psychosocial interventions for depression in HIV-infected youth in Southern Africa. One 
included HIV-infected participants exclusively (n=59 completed follow up; Bhana et al., 
2014); the other included only a small proportion of participants who self-reported to be 
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HIV-infected (n=36; Mueller, Alie, Jonas, Brown, & Sherr, 2011). A request was made 
to the authors of this study, but it was not possible to obtain data for the HIV-infected 
participants. As a result, the conclusions that can be drawn from this study are very 
limited. 
Both studies used the CDI-S as the measure of depression. While Bhana et al.’s 
(2014) sample (age 10–13) were clinically-verified as being HIV-infected, Mueller et al. 
(2011) relied on self-report from their participants (age 8–18). Bhana et al.’s (2014) 
pilot-RCT randomly allocated participants to treatment or control groups, whereas 
Mueller et al. (2011) used arbitrary allocation, which resulted in a high number of 
significant differences in between-group characteristics. In addition, Mueller et al. 
(2011) used a quasi-experimental design with outcome measurement at only one time 
point, whereas Bhana et al. (2014) used a pre-post design. Bhana et al.’s (2014) youth-
caregiver CHAMP-adapted intervention was described, with curriculum provided. 
Mueller et al.’s (2011) MAD About Art intervention did not provide an adequate 
description. Bhana et al. (2014) scored 8 using the quality assessment tool (possible 
range 0-17), while Mueller et al. (2011) was rated very poor quality with a score of 2. 
 
Findings. Bhana et al. (2014) used generalised linear models to compare 
intervention and control groups over time, which accounted for the effect of repeated 
measures. Mueller et al. (2011) used linear regression to measure association between 
intervention attendance and depression in the whole sample, regardless of HIV status. 
Neither intervention was found to have a significant effect on depression. 
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Discussion 
This review sought to identify risk factors for depression in HIV-infected youth 
in Southern Africa and evaluate potential psychosocial interventions.  
Six studies were identified that collected data pertaining to risk factors, but 
qualitative synthesis was based largely on three studies that explored this question 
explicitly and reported data separately for HIV-infected participants. 
 
Demographic Factors 
This review found female gender to be associated with higher depressive 
symptoms, but not with presence of depression when using cut-offs. Female gender has 
been identified as a risk factor for depression in HIV-infected adults in Southern Africa 
(Olley, Seedat, Nei, & Stein, 2004), as well as in the general population, including in 
Southern Africa (Bromet et al., 2011; Nduna, Jewkes, Dunkle, Jama Shai, & Colman, 
2013; Salk, Hyde, & Abramson, 2017; Tomlinson, Grimsrud, Stein, Williams, & Myer, 
2009). A recent meta-analysis found that this gender difference is not present in young 
childhood, but starts emerging at around age 12 in the general population (Salk et al., 
2017). The current review found some evidence of an association between depression 
and older age in participants age 12–19, but no gender and age interactions were 
reported. As the sample in this review was limited to those aged 12–19, future research 
could benefit from broadening the age range to explore this interaction further. This 
could also allow risk factors to be categorised by age range and suitable interventions 
tailored accordingly. 
The findings in this review provide some evidence for an association between 
food insecurity and depression, but no association between household income and 
depression. The fact that food security was not significantly associated with depression 
in Bhana et al.’s (2015) study when controlling for age, gender and study indicator may 
be because the two samples (pilot and main RCT) were recruited from different 
locations and differed significantly in the number of individuals experiencing food 
insecurity. Southern African studies of youth where HIV-status has not been assessed 
have also found food insecurity to be a strong predictor of depression (Bachman 
DeSilva et al., 2012; Collishaw, Gardner, Aber, & Cluver, 2016). American studies that 
have made distinctions between food insecurity and poverty, have found only the former 
to be associated with depression in youth (Alaimo, Olson, & Frongillo, 2002; Slopen, 
Fitzmaurice, Williams, & Gilman, 2010). 
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In this review lower level of schooling was associated with depression, which is 
consistent with findings from a national household survey administered across South 
African adults between 2002-04 (Tomlinson et al., 2009).  
Of the studies in this review, the only one to use caregiver depression as a 
variable found no association with depression in HIV-infected participants (Bhana et al. 
2016). In contrast, other Southern African studies have found that general emotional 
difficulties in HIV-infected youth are associated with caregiver depression (Lentoor, 
Asante, Govender, & Petersen, 2016; Louw, Ipser, Phillips, & Hoare, 2016), although 
Louw et al. (2016) found this to be a weaker association in HIV-infected, compared 
with HIV-uninfected, participants. 
There is some preliminary evidence that certain household characteristics, such 
as water source, may have an association with depression, but the number of eligible 
participants from Målqvist et al.’s (2016) dataset was very low, reducing the reliability 
of the results. A surprising finding was that looking after a sick person in the home was 
related to lower levels of depressive symptoms (Woollett et al. 2017). It is possible that 
looking after a sick person can provide youths with a sense of purpose, which may be 
protective against depression. However, looking after younger children in the family 
was not found to be associated with depression. As a stand-alone finding in a single 
paper, this warrants further investigation. 
 
Social and Community Support 
This review found some evidence that both knowing one’s HIV-status and 
disclosing it to others can be protective against depression in HIV-infected youth. This 
is important given that prevalence of disclosure to HIV-infected children in resource-
poor settings is low (Vreeman, Gramelspacher, Gisore, Scanlon, & Nyandiko, 2013). 
Research on disclosure has largely focused on its association with ART adherence, with 
limited research on its psychological impact (Vreeman et al., 2013). Studies that have 
assessed psychological impact of disclosure have produced mixed findings. Self-
reported emotional difficulties were found to be lower in HIV-infected Zambian youth 
who know their status compared with those who do not (Menon, Glazebrook, Campain, 
& Ngoma, 2007), while caregiver-ratings in Kenya indicated significantly higher 
depressive symptoms in HIV-infected youth who knew their status (Vreeman et al., 
2014). This review assessed the impact of knowing one’s status in samples where a high 
proportion of participants were aware of their status: 81% (Kim et al, 2015); and 88% 
(Woollett et al, 2017). This may be a consequence of the fact that participants were 
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recruited directly through ART clinics and, therefore, these samples may not be 
representative of the wider HIV-infected youth population. 
Wider research on the association between depression and disclosure to others is 
also mixed. A study of HIV-infected youth in Namibia found disclosure to others to be 
associated with more mental health difficulties, although there was no direct association 
with emotional symptoms (Gentz, Calonge Romano, Martínez–Arias, & Ruiz–Casares, 
2017). Qualitative studies have found that youth in South Africa who disclosed to 
teachers generally experienced increased academic support, but disclosure revealed via 
gossip could result in discrimination and stigma (e.g., Petersen et al., 2010). Lam et al.’s 
(2007) study of American 16–25 year olds found disclosure to acquaintances was 
associated with increased distress, while disclosure to close family friends was not, 
indicating that perhaps measures of disclosure need to be more nuanced than those 
employed in this review. 
The fact that higher caregiver supervision and likelihood of seeking social 
support were identified as protective factors against depression is consistent with wider 
literature about the positive impacts of social support for HIV-infected youth 
(Abramowitz et al., 2009; Breuer et al., 2011; Gentz et al., 2017; Lam et al., 2007).  
 
Past Trauma/Stressors 
This review highlighted mixed findings regarding the impact of violence on 
depressive symptoms. Although Woollett et al. (2017) found an association between 
depression and several violence variables, witnessing somebody being stabbed or shot 
was not found to be associated with depression. In line with this, Skeen et al. (2016) 
recruited both HIV-infected and uninfected participants and found interpersonal 
violence in the home to be associated with higher depression scores, while community 
violence was not; this remained the case when controlling for HIV status. Community 
violence was related to trauma symptoms in youth (Skeen et al. 2016) suggesting that, 
while this does have a psychological impact on youth in Southern Africa, it does not 
appear to manifest as depression. 
In line with Woollett et al.’s (2017) findings described in this review, Gentz et al. 
(2017) found no association between orphanhood status and mental health problems. 
Sherr et al. (2014) recruited both HIV-infected and uninfected participants and found “a 
trend” towards elevated depression in double orphans, although this was non-
significant.  
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Psychosocial Factors 
The association between internalised stigma and depression found in this review 
is consistent with research on HIV-infected adults in sub-Saharan Africa (Breuer et al., 
2011; Pantelic, Shenderovich, Cluver, & Boyes, 2015), and emotional difficulties in 
HIV-infected youth in Namibia (Gentz et al., 2017). This has implications for 
intervention; indeed, a study on HIV-infected adults in South Africa found that a stigma-
reducing intervention significantly reduced depressive symptoms (Chidrawi, Greeff, 
Temane, & Ellis, 2015). The fact that lower self-concept, social withdrawal and 
resignation were linked to depression offer potential targets for psychosocial 
interventions. 
 
Factors Not Assessed 
ART adherence was not assessed in this review, despite a well-established 
association between ART adherence and depression in HIV-infected youth outside of 
Southern Africa (Agwu & Fairlie, 2013; Murphy et al., 2001; Naar-King et al., 2006). 
There is also some evidence in wider literature for the following factors: level of 
disability (Olley et al., 2004); route of transmission (Tanney, Naar-King, & MacDonnel, 
2012; Walsh et al., 2017) and sibling relationships (Snead, 2011). Other factors have yet 
to be assessed in relationship to depression, but may be pertinent. For example, a recent 
study identified significant cognitive differences between HIV-infected and HIV-
uninfected participants (Sherr, Hensels, Tomlinson, Skeen, & Macedo, 2018), but the 
association between cognitive function and depression has yet to be assessed.  
 
Interventions 
Only two intervention studies were identified, consisting of a family programme 
and a school-based art intervention. Only the family programme recruited HIV-infected 
youth exclusively. Neither interventions led to a significant reduction in depression. 
Literature on interventions for HIV-infected youth outside of Southern Africa is also 
sparse. A global review of interventions for depression in HIV-infected individuals 
(Sherr et al., 2011) only identified one study of adolescents, which was USA-based and 
used massage as the intervention (Diego et al., 2001). Although the review found 
psychological interventions to be particularly effective in reducing depression, the 
populations studied make the findings unlikely to be generalisable to Southern African 
youth. In addition, interventions to be implemented in Southern Africa need to take 
account of the resource-poor context. A recent review identified 18 community and 
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school-based intervention studies that assessed depression as an outcome in youth 
across low and middle-income countries (Yatham, Sivathasan, Yoon, da Silva, & 
Ravindran, 2017). Of these, seven demonstrated a significant reduction in depression. 
These interventions, though not tailored to HIV-infected youth, are evidence for the 
feasibility of community-based interventions in resource-poor settings and indicate that 
they can be effective in reducing depression. In South Africa, there is evidence that 
community-based organisations (CBOs) are accessible to vulnerable youth and 
attendance is associated with reduced depression (Yakubovich et al., 2016). CBOs may 
therefore be a potential target for future interventions. 
 
Strengths and Limitations 
A strength of this review is the use of a clear, systematic search across four 
databases. Study screening, study selection and quality assessment were conducted by 
two independent researchers to reduce bias. 
There are several limitations of this review. The dearth of research in the field 
means results cannot be confidently generalised and robust conclusions cannot be 
drawn. Measures of depression used in this review mainly relied on the adaptation of 
Western-developed measures, using Western conceptualisations of depression, with 
alternative terminology either agreed by researchers or developed from a small sample 
of participants (Kim et al., 2014; Snider & Dawes, 2006). The construct validity of these 
measures can therefore be questioned. In addition, data on risk factors were derived 
exclusively from cross-sectional studies, which presents the problem of determining 
causality between depression and associated variables. The lack of control groups in the 
risk factor studies, and the lack of mental health research in Southern Africa more 
generally, means it is unclear which risk factors are specific to HIV-infected youth and 
which are relevant to youth generally. 
 
Clinical Implications 
The shortage of research on depression in HIV-infected youth limits the clinical 
implications that can be drawn from this review. Based on the findings, neither art 
programmes, nor family-based CHAMP-model interventions can be recommended for 
reducing depression in HIV-infected youth. Results of factors associated with 
depression provide some preliminary evidence for potential targets for intervention. For 
example, family-based interventions may benefit from working to increase caregiver 
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supervision and supporting caregivers to inform youths of their HIV status. Schools 
offer a viable method of delivering large-scale, low-cost interventions. School-based 
interventions may benefit from focusing on reducing internalised stigma and reducing 
bullying of those taking medication, as well as supporting safe disclosure of HIV status 
to others. While having a safe community space was identified as a protective factor, 
not al youths had access to one. This provides support for CBOs and offers another 
potential target for delivering large-scale, low-cost interventions. 
 
Future Research 
While much of the psychosocial research on youth in Southern Africa refers to 
the high HIV prevalence of the area, or focuses on those affected by HIV (i.e. caring for 
a HIV-infected family member or orphaned by HIV/AIDS), most of these studies failed 
to record the HIV status of youth themselves, despite them being at higher risk of 
infection. HIV leads to biological and neurochemical changes and can have specific 
psychological and social consequences. Results from this review has indicated several 
HIV-specific variables that appear to be associated with depression, including 
immunosuppression, internalised stigma and being bullied for taking medication. It is 
therefore not sufficient to generalise findings from HIV-uninfected youth; future 
research should record HIV status of youth to improve our understanding of risk factors 
relevant to this population so that interventions can be tailored appropriately.  
Further research is needed to find effective interventions for depression that are 
possible to deliver in the resource-limited setting of Southern Africa. To optimise 
viability, interventions would likely need to be community or school based, and may 
involve training of teachers or other community workers to deliver interventions. 
 
Conclusions 
Despite the high prevalence of HIV in youth in Southern Africa, this review has 
identified a distinct lack of research on HIV and depression in youth in these countries. 
Some preliminary evidence for potential risk factors is presented, which offer 
possibilities for the focus of interventions, but substantially more research is needed. 
Future research should consider measuring HIV status as standard and conducting 
separate or comparative analysis for this participant group. Research on interventions is 
severely lacking, but wider literature can offer some suggestions for community-based 
interventions that take account of the impoverished setting.   
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Abstract 
National guidelines outline that clinical staff working in cancer services should be 
provided with clinical supervision. In Great Western Hospital Trust, clinical 
psychologists run supervision groups for clinical nurse specialists working in cancer and 
palliative care using the Structured Approach to Collaborative Supervision (SACS) 
model. This project aimed to evaluate the implementation of this supervision model 
based on literature about the functions of supervision and mechanisms of change within 
those functions. A mixed methods design was used. Results indicated that, generally, 
supervisees felt the normative, formative and restorative functions of supervision were 
being well met by the SACS model. Guidance, reinforcement, structure, and learning 
through others were all identified as mediators for achieving supervision outcomes 
within these functions. Based on the results, several recommendations were made to the 
service to offer potential improvements to the SACS supervision groups. 
 
Keywords:  clinical supervision; supervision model; oncology 
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Introduction 
NICE (2004) guidelines for cancer services recommend a four-tier model of 
psychological assessment and support. The model outlines that all health and social care 
professionals working within cancer services should provide patients with 
compassionate communication and general psychological support. Subsequent tiers 
represent additional training and expertise, enabling higher levels of psychological 
assessment and support (see Figure 1). The guidelines state “those working at the higher 
levels of the model should normally provide training, supervision and opportunities for 
continuing professional development for those operating at the lower levels” (p.82). 
Clinical psychologists within cancer services are therefore well-positioned to provide 
supervision for tier one and two clinicians (London Cancer Alliance, 2015; National 
Cancer Action Team, 2010) 
Figure 1. Recommended four-tier model of psychological assessment and support 
(NICE, 2004) 
 
Definitions of clinical supervision vary across settings. The Department of 
Health defines clinical supervision as: “a formal process of professional support and 
learning which enables individual practitioners to develop knowledge and competence, 
assume responsibility for their own practice and enhance consumer protection and 
5.20 The model encompasses the range of psychological skills and
expertise on which patients may draw and represents the
diversity of psychological skills covered by different professional
disciplines.  The function of each level of provision is as
follows.
Level 1 
5.21 Involves all staff directly responsible for patient care and is
focused on general emotional care.
Assessment 
5.22 All health and social care professionals should be able to
recognise psychological distress and should be sufficiently
competent to avoid causing psychological harm to patients and
carers.  They should know when they have reached the
boundary of their competence and should refer the patient to a
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safety of care in complex clinical situations” (DoH, 1993). Bridget Proctor’s model 
(Proctor, 2001) outlines three functions of supervision: formative (skill and knowledge 
development); normative (professional accountability); and restorative (support). A 
review of clinical supervision definitions found they most often emphasised promoting 
professional development and ensuring patient safety (Kilminster & Jolly, 2000); thus, 
prioritising the formative and normative aspects of supervision. However, a review of 
clinical supervision in nursing found restorative aspects of supervision (e.g. burnout; 
tedium; relationship with other nurses) were most researched and nurses tended to focus 
on restorative aspects during unstructured interviews (Brunero & Stein-Parbury, 2008). 
Clinicians in cancer services are continually working with serious illness, death and 
bereavement; in this context, restorative aspects of supervision are therefore important 
in maintaining clinician wellbeing, avoiding burnout and sustaining the delivery of high 
quality care (Pereira, Fonseca, & Carvalho, 2011; Sinclair & Hamill, 2007). As such, 
guidelines for supervision in cancer services often make explicit reference to exploring 
the impact of the work on the self (Criddle, 2015; Pan Birmingham Cancer Network, 
2010). 
Supervision models have generally attracted criticism for often having little or 
no empirical basis (Kilminster & Jolly, 2000). Evidence-based literature reviews have 
attempted to improve our empirical understanding of supervision; Brunero and Stein-
Parbury (2008) identified 22 studies that evaluated clinical supervision in nursing and 
categorised supervision outcomes by function according to Proctor’s model (see Figure 
2). Another systematic review (Milne, Aylott, Fitzpatrick, & Ellis, 2008) identified 24 
supervision studies with rigorous designs and categorised outcomes according to their 
mechanism of change using Kolb’s (1984) experiential learning cycle. Kolb’s learning 
cycle is the most widely used learning theory and involves four elements, which can be 
broadly understood as: (a) experiencing; (b) reflecting; (c) conceptualising; and (d) 
experimenting. These empirical approaches are compatible; whilst Proctor’s model 
categorises the functions of supervision, Kolb’s model may help us to understand the 
mechanisms of change within each function. 
Within cancer services, a common practice is for clinical psychologists to run 
supervision groups for nurses (Criddle, 2015; London Cancer Alliance, 2015). Several 
models of group supervision have been described in supervision literature (e.g. 
Arvidsson, Löfgren & Fridlund, 2001; Edmunds, 2013; Lassiter, Napolitano, Culbreth 
& Ng, 2008). Most share the format of one supervisee at a time presenting a question or 
case, before other supervisees respond. However, the focus and method of 
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implementation varies significantly according to the model. For example, supervisees 
may be asked to prepare a case, bring materials, or to speak spontaneously about a piece 
of work. Other group members may be encouraged to reflect on their own emotions or 
offer direct advice. Qualitative studies have identified that attendees of group 
supervision report benefiting from hearing multiple perspectives; learning vicariously 
through others (Carter, Enyedy, Goodyear, Arcinue, & Puri, 2009); and improved 
cohesion with teams (Jones, 2003), but benefits and supervision outcomes are likely to 
vary according to the supervision model used.  
Figure 2. Reported outcomes of supervision, categorised according to Proctor’s model 
(Brunero & Stein-Parbury, 2008) 
 
In line with good practice (National Cancer Action Team, 2010; NICE, 2004), 
Great Western Hospital NHS Foundation Trust (GWH) provide group supervision to 
cancer nurses. Groups are run monthly or six-weekly by clinical psychologists using the 
Structured Approach to Collaborative Supervision (SACS) model. SACS (see Appendix 
C) was created by Linda Charles, a psychologist who provides national supervisor 
training for the BPS. SACS allocates roles to those attending the group: facilitator; case 
presenter; co-supervisors; and scribe. Within GWH, clinical psychologists take the 
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evaluative literature emerged in 1993. Searches of 
Medline, CINAHL, PsycINFO and Cochrane database 
were undertaken. The searches were limited to 
reports of research published in peer-reviewed 
journals. Studies were selected for review on the 
following basis: the article was an evaluation of the 
effectiveness	of	CS;	the	participants	were	qualified	
nurses (not students); the approach to CS was clearly 
described; and, the method of data collection and 
analysis included either quantitative and qualitative 
data, or both. There were no other restrictions in 
terms of setting, clinical speciality or whether CS was 
undertaken in a group or a one to one basis.
RESULTS
A t tal of 32 articles were initially located: of 
those studies, 22 met the criteria for inclusion in 
this	 research.	Studies	were	first	grouped	by	 three	
different types of research design; four studies were 
considered to be comparative, three were pre-post 
evaluation studies and fifteen were post-only 
evaluation studies. Therefore in the majority 
of studies, CS was evaluated after it had been 
implemented. There maybe several reasons for 
this:	first,	is	the	lack	of	a	well‑validated	and	reliable	
measures of CS effectiveness; second, in nursing 
there is strong interest in qualitative research and in 
addition, there is a lack of funding for well-designed 
trials	of	CS;	and	finally,	the	opportunistic	nature	of	
post evaluation. Sample sizes varied and ranged 
from 10 to 660 in one of the post survey evaluations 
(Magnusson et al 2002). Mental health nurses and 
aged care nurses are dominant in the samples 
studied.
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facilitator role. Each session, two nurses take turns as case presenter. The case presenter 
outlines a supervision question, provides a 5-7 minute description of the case, then 
chooses a method of feedback from six options: sounding board; advice; show me; 
reflecting team; brainstorming or flip the question. Co-supervisors use the chosen 
method to help answer the supervision question. Finally, the case presenter reflects to 
the group specific points they will take forward. Sessions are 60–75 minutes long. 
Conceptually, SACS is congruous with both Proctor’s (1991) and Kolb’s (1984) 
models. Case presenters choose a supervision question which could link with normative, 
formative or restorative aspects. SACS uses co-supervisors to support reflection and 
case presenters are encouraged to conceptualise their learning and plan active 
experimentation. This active focus on the learning cycle in supervision is believed to 
lead to better patient outcomes (Kilminster & Jolly, 2000). Theoretically, SACS offers a 
replicable framework that could fulfil Proctor’s functions of supervision, by facilitating 
Kolb’s learning cycle. However, SACS has yet to be evaluated in its effectiveness. This 
project aims to evaluate the effectiveness of SACS for cancer nurses at GWH and 
develop recommendations on how to improve supervision effectiveness. 
 
Evaluation questions 
• How effective is the SACS model of group supervision at providing formative, 
normative and restorative functions of supervision for supervisees? 
• How does SACS facilitate supervision outcomes in relation to Kolb’s learning 
cycle? 




A mixed-methods cross-sectional design was used, using questionnaire and 
focus group data. 
 
Participants 
Individuals were eligible to participate if they attended any of the three SACS 
supervision groups at GWH. Participants were cancer nurses who had undertaken level 
two psychological support training (NICE, 2004). See Table 1 for composition of 
supervision groups at time of data collection and Figure 3 for flowchart of recruitment. 
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Table 1. Characteristics of supervision groups; all members eligible for participation 




Duration of group at 
time of project 
Group A Psychologist 1 6 Monthly Six months 
Group B Psychologist 2 6 Six-weekly One year 
Group C Psychologist 2 5 Monthly Two years 
 
Evaluation Questionnaire 
A questionnaire previously developed to evaluate a level two cancer supervision 
group (BPS, 2015), was adapted to evaluate the past six months of supervision, rather 
than session-by-session (see Appendix D). The questionnaire consists of 11 positive 
statements about supervision; participants are asked to rate level of agreement with each 
statement from 1–5. A twelfth item asks participants to rate their confidence in 
discussing psychological problems with patients with cancer, from 1–10.  
Each item on the evaluation questionnaire was categorised according to the 
supervisory function it best measured (formative, normative or restorative). 
Categorisation was done by two independent raters, with good agreement. 
Discrepancies were resolved by a third rater. See Table 2 for item categorisation. 
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Focus Group Questions 
Broad focus group questions were developed to allow for more in-depth 
evaluation of how SACS facilitates Kolb’s learning cycle to meet the three functions of 
supervision. More specific focus group questions were developed based on lowest-
scoring items from completed evaluation questionnaires and focused on how these 
outcomes could be better met. Focus group questions were based on scores from the 
nine quantitative questionnaire respondents who returned their responses prior to the 
focus group (Group A=5; Group B=4). See Table 3 for focus group questions. 
Table 2. Categorisation of items in evaluation questionnaire and mean scores 














1. I feel that this group is a safe space to reflect, 
ask questions, share my ideas and experiences   
Restorative 4.8 3.7 4.1 
2. I feel supported by other people in the group Restorative 4.8 4.0 4.3 
3. When I have shared something with the 
group I felt heard by them 
Restorative 4.8 4.2 4.4 
4. I feel that other group members treated my 
contribution with respect when I shared 
something with them   
Restorative 4.8 4.2 4.4 
5. I feel reassured that what I am doing as a 
professional to support cancer patients is good 
enough  
Normative 4.4 3.8 4.0 
6. I feel that the way cases are discussed in this 
group is helpful for me  
Formative 4.8 3.0 3.6 
7. By attending the group, I have considered 
how I look after myself  
Restorative 4 2.7 3.1 
8. I have regularly shared or addressed issues 
relevant to working with cancer patients 
Normative 3.6 3.7 3.6 
9. I have come away from the group 
understanding a bit more about the experience 
and needs of a person with cancer 
Formative 5 2.9 3.6 
10. As a result of attending the group I 
understand more about responding to patient 
distress   
Formative 4.6 3.1 3.6 
11. I have learnt something useful about how to 
deal with challenging situations with my 
patients and their families 
Formative 4.8 3.3 3.9 
12. Overall, how confident do you feel about 
discussing psychological problems with your 
patients with cancer? (Scored out of 10) 
 8.5 7.8 8.3 
Note: Items 5, 6, 7 and 8 used to develop questions for focus group based on scores from questionnaires 
received prior to group 
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Procedure 
Nurses were invited to complete the evaluation questionnaire at the end of one 
of their supervision sessions. Information sheets about the project were provided 
alongside paper copies of the evaluation questionnaire. Envelopes and boxes were 
provided and the facilitator left attendees alone to allow anonymous submission. 
All 17 supervision attendees were invited, via email, to attend a focus group. 
Only four attended, all of whom were from Group A. It was reflected by the researchers 
that Groups B and C had been provided with less notice of the focus group than Group 
A, which may have inhibited their attendance. To allow Supervision Groups B and C a 
further opportunity to provide feedback, anonymous online questionnaires were emailed 
to attendees of these groups. This consisted of the evaluation questionnaire (which 
could be skipped if participants had already completed it), as well as four optional 
qualitative questions based on the focus group questions.  
Focus group attendees and online questionnaire respondents were also asked to 
rate how well supervision groups adhere to SACS from 0–10. 
 
Ethics and Governance 
University of Bath ethical approval was obtained. Great Western Hospital Trust 
also granted approval for this evaluation (Appendix E). 
 
Qualitative Data Analysis 
Thematic analysis was carried out according to Braun and Clarke (2006), using a 
realist method. An inductive approach was taken to coding and the identification of 
themes at the semantic level. However, the researchers acknowledge that prior 
knowledge of relevant literature and development of the research question will have 
informed interpretation of themes. The primary researcher was a trainee clinical 
psychologist who had not previously run supervision groups and had no personal 
experience of SACS. 
The focus group was orthographically transcribed, to include all verbal and non-
verbal utterances. The transcript was then read several times and initial notes about 
patterns and potential codes were made. The entire transcript was then systematically 
coded using NVivo, with the same piece of text often categorised under multiple codes. 
Responses to qualitative items in the online questionnaire (n=4) were also coded. Codes 
were then grouped into themes and sub-themes using a thematic map format. Different 
iterations of mind-maps were saved in order to preserve the audit trail (Nowell, Norris, 
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White, & Moules, 2017). During the refinement phase (Braun & Clarke, 2006) quotes 
were checked against themes and changes were made so that themes appeared in a 
coherent pattern (Nowell et al., 2017). To improve robustness, peer debriefing with an 
independent researcher was used to support the defining and naming of themes (Nowell 
et al., 2017). This led to further refinements to theme structures and names; all changes 
were recorded. 
 
Table 3. Main questions asked in semi-structured focus group 
• What is your understanding of supervision in Cancer Nursing care? 
• What do you find most useful about attending supervision groups? 
• How could the supervision groups be improved? 
• How could supervision ensure that everybody in the group is able to 
regularly share, or address issues relevant to cancer patients? 
• How could the supervision groups improve how you look after 
yourselves, as individuals and as teams? 
• How could the supervision groups help you to feel more reassured 
that what you are doing as a professional, to support cancer patients, 
is good enough? 
• What’s helpful and unhelpful about the way that cases are discussed 





Scores across all three supervision groups produced a mean of 3.8 out of five for 
normative items; 3.7 for formative items; and 3.2 for restorative items. There were 
differences in scores between groups, with Groups B and C demonstrating lower 
agreement than Group A on 11 of the 12 questionnaire items. All responses are 
summarised in Table 2.  
 
Adherence to the Model 
Nine participants rated adherence to SACS. Mean rating was 9 (range 8–10), 
indicating high adherence to SACS across supervision groups. 
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Summary of Thematic Analysis Findings 
Four main themes were identified from the qualitative data: (1) dedicated space; 
(2) value of supervision; (3) mediators for supervision outcomes; and (4) challenges. 
Each theme contained sub-themes, as illustrated in Figure 4. Participants 1–4 are focus 
group attendees and participants 5–8 completed the online questionnaire. 
 
 
Figure 4. Thematic map illustrating four main themes with sub-themes 
 
Dedicated Space 
Supervision groups were viewed as a dedicated time and space, with 
characteristics and qualities that make it distinct from both clinical work and other 
forms of support. Within this theme were three sub-themes: (a) importance of feeling 
safe, which was further divided into (i) group composition and (ii) facilitator; (b) 
separation from clinical environment; and (c) freedom for open reflection. 
Feeling safe. Participants reflected on aspects of group supervision that made 
them feel comfortable in discussing issues. These could be conceptualised into two 
smaller themes. 
Group composition. The make-up of the group, both in terms of size and 
characteristics of other supervisees, was important to participants. Focus group 
participants felt it was important that there were not too many members in their 
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I think if it got much bigger, (a) we wouldn’t have the opportunity to talk, but 
also, you’d feel probably less comfortable if there’s like a massive group. 
(Participant 2) 
 
 An online participant noted a difficulty that can occur in having smaller groups. 
 
Groups are small—people don't always have examples to share or things to say 
(Participant 7) 
 
It was recognised that interpersonal relationships between supervisees is an 
important aspect in allowing them to feel safe to discuss certain issues. 
 
The people who you’re with, you know, it has to work, doesn’t it really? And not 
everybody will necessarily gel with everyone, so I think that, that would have an 
impact, but I think, it works quite well (Participant 4) 
 
 Working relationships with other supervisees were also considered; participants 
reflected that being supervised with others outside of their immediate team made it 
easier to discuss any issues relating to colleagues. Issues of power difference between 
group members was also touched upon.  
 
You might have something that you wanna discuss that’s quite sensitive. Wouldn’t 
necessarily feel that you could do that…if you were in with your line manager. 
(Participant 2) 
 
Characteristics of the facilitator. Participants reflected that they felt safe being 
led by the facilitator, which was important for feeling comfortable participating in 
discussions. 
 
You don’t feel daft about saying things. Well you might still feel daft, but she 
doesn’t make you feel, you know, um, just accepts it as it is (Participant 4) 
 
For some this differed to previous experiences and so participants identified the 
characteristics of the facilitator that allow them to feel safe.  
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Participant 1: She’s friendly, she listens. Not judgemental. 
Participant 3: She’s very calming as well. 
Participant 4: Reassuring, isn’t she? 
 
Separate from clinical environment. Participants spoke about supervision 
groups offering a protected, dedicated time that allowed space to reflect, that would not 
otherwise be available to them.  
 
Work is very busy and it gives staff the time to look and reflect on challenging 
situations (Participant 6) 
 
Otherwise the opportunity’s not there, apart from in these sessions  
(Participant 2) 
 
The physical separation from the everyday clinical environment seemed to be 
important in facilitating an appropriate atmosphere. 
 
But when you’re in a clinic room, next to consultant clinics that are running, in 
your normal clinical area…shoving chairs all in…like literally teeny, and you’re 
all clumped together, it just doesn’t feel right, for that sort of session. Whereas 
now…we’re in a separate room. It’s a bit more comfortable. (Participant 2) 
 
Freedom for open reflection. Participants emphasised that these supervision 
groups allowed them to discuss issues other than patients and relatives—for example, 
work relationships or relevant personal issues. Participants therefore felt that 
supervision gave them permission and freedom to talk about things that otherwise did 
not get addressed. 
 
Yeah. And it’s not just patients or relatives. We’re allowed to talk about 
colleagues, or, peers, or whoever (Participant 2) 
 
What’s nice about this is we can talk about things outside of work, so if things 
from our personal life are impacting, whereas before we were told we couldn’t, 
but now, we can (Participant 3) 
 
EVALUATION OF SACS SUPERVISION GROUP      53 
 
[There] is a link between home and work and sometimes they cannot be 
separated and do have an impact with how with [sic] manage situations at work 
(Participant 5)   
 
Value of Supervision   
This theme related to the value that participants saw in attending supervision 
groups and meaning it had to them. It was further divided into three sub-themes: (a) 
feeling supervision is useful; (b) value of case discussion to improve clinical work; and 
(c) self-care.  
Feeling supervision is useful. Participants reflected the importance of feeling 
that they gained something from attending supervision and this impacted their 
motivation to attend. Some participants reflected on past experiences where the gains 
had been less clear to them. 
 
 I just pulled out, because I didn’t get anything out of it (Participant 4) 
 
So before, when we started supervision we had nothing to compare it to and we 
thought “oh, well if this is it…do we really need to come?” (Participant 3) 
 
Comparisons were drawn with the current groups where participants feel 
supervision is more useful. 
 
It felt like it was a bit more, to do with what somebody else needed to tick off, 
rather than what you were actually getting out of it. But now, you know, I 
certainly feel like I get something back (Participant 2) 
 
There’s no more time in the day, but you feel like you’re getting something back, 
so therefore there’s more meaning to it, so therefore it is something I want to do. 
Whereas before, it was just like “oh, it’s that time of the month again, 
[inaudible] I really can’t do this” (Participant 2) 
 
Myself and my colleagues have appreciated this service (Participant 6) 
 
Value of case discussion to improve clinical work. A supervision outcome that 
related to the value of supervision was the benefits for future clinical work.  
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So then future appointments or conversations or if we’re meeting with that, that 
person, you know, if, if they’re acting or, or coming across in the same way, it 
helps you deal with it, better (Participant 4) 
 
So you can then look at it from a different angle and think “actually yeah, I 
could’ve done that” or “I did do that, but this happened” or, and sort of, take it 
from that experience (Participant 1) 
 
Self-care. Participants reflected on benefits of supervision that related to caring 
for themselves and this contributed to the value of supervision.  
 
It’s also self protection isn’t it? Looking after yourself and…talking about things 
that you may not have, normally have time to talk about (Participant 3) 
 
Well from the nature of the…, you know, the fact that they’ve got cancer, we often 
find…patients can present with feelings of anger or…sadness, or loss, and 
sometimes it’s directed at us, but it might not be directed at us, if you see what I 
mean. So it’s dealing with, how that makes you feel, as well as how you deal with 
the situation when it’s happening. ‘Cause it can feel personal sometimes. 
(Participant 2) 
 
To ensure that our 'well being' is being addressed and managed. (Participant 5) 
 
 However, participants recognised there may be further opportunity to do this. 
 
Talking about strategies of how to, look after ourselves, so, like a session on that 
would be good (Participant 1) 
 
Mediators for Supervision Outcomes 
This theme captures how participants believe supervision facilitates the 
outcomes of caring for self and improved clinical work identified in the previous theme. 
There are four sub-themes: (a) guidance; (b) reinforcement; (c) structure providing 
focus; and (d) learning through others. 
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Guidance. Participants noted that the facilitator has a role in guiding 
supervisees. This was linked to having a different professional background and 
approaching things from a different angle. 
 
You’ll kind of say, “well this is what I’d like to talk about, but I’m not quite sure 
how to structure it” and she’ll kind of, say, “what about this?”...She’ll guide you 
as well (Participant 2) 
  
 Reinforcement. Participants spoke about feeling reassured that what they were 
doing was acceptable and feeling validated by others doing similar roles. 
 
I think it validates what you do, doesn’t it, so if you, if you bring a case and 
discuss it, “oh yeah, I would have done that”, like it just gives you validation 
that you’re doing things ok (Participant 3) 
 
Structure providing focus. Throughout the focus group data, participants spoke 
about the helpfulness of having the SACS structure. Participants noted that they know 
what format to expect and this allows them to prepare for supervision. Again, this 
contrasted with some participants’ past experiences of supervision. 
 
I think before, we used to just, we used to just turn up, I’d struggle to think about 
something to talk about, but now I know how it’s going to be structured then I 
can relate it to a certain scenario, to how it’s going to work in the session, if that 
makes sense (Participant 2) 
 
Because there’s a question at the beginning you’ve got to think about what your 
scenario is and then you get the opportunity to talk (Participant 2) 
 
Before it just seemed to be an offloading session (Participant 3) 
 
Learning through others. Participants spoke about the usefulness of hearing 
others’ perspectives and using this as a way of generating new ideas.  
 
EVALUATION OF SACS SUPERVISION GROUP      56 
 
And then hopefully get some feedback on, from others, that we know, do similar 
roles to, to us as to how that went and how we could maybe do things better in 
the future (Participant 1) 
 
I think that if we’d have had individual supervision at the moment, I think you’d 
learn from it, but I think you learn more as a group. (Participant 1) 
 
Participants clearly valued hearing ideas from others. This was demonstrated 
when participants spoke about how they choose how to receive feedback from others 
during supervision groups.  
 
Participant 2: And being able to choose how you have your feedback. 
Moderator: And how does that work in practice? 
Participant 2: We always go for the same one [laughs] 
Moderator: do you? 
[laughter] 
Participant 4: I was gonna say…we’re creatures of habit!…I think someone, I 
think <name> chose the reflecting team, dun’t she? 
Participant 1: Mmm 
Participant 2: But generally…I think it is the brainstorming one 
Participant 3: We don’t do the roleplaying one 
 
Some participants spoke about learning through others by simply observing and 
allowing more experienced supervisees to model. 
 
It’s just a learning curve for me to just absorb how, you know, the rest of my 
colleagues deal with things, before I speak up about anything (Participant 1) 
 
Challenges 
Although focus group participants were very positive about their experiences of 
supervision, the dataset also captured some challenges related to attending the SACS 
supervision groups, which were divided into two subthemes: (a) uncertainty around 
presenting cases; and (b) feeling insecure/anxious. 
Uncertainty around presenting cases. Some participants expressed uncertainty 
around what constituted a ‘good case’ to discuss in the groups. One participant spoke 
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about thoughts that the case presented at supervision had to have specific 
characteristics. 
 
Participant 4: I’d have to cause a row somewhere [laughs], no, but…I wouldn’t 
like that…’cause then the pressure’s on 
Moderator: …what would the pressure involve? 
Participant 4: Coming up with a scenario that you can talk about 
Moderator: Ok. Does it feel like the scenario’s got to be a certain way? 
Participant 4: Be a goodun [laughs] well to be juicy enough to talk, that’s how I, 
yeah, that’s, I suppose how I perceive it 
 
There was also some doubtfulness about the usefulness of discussing cases if 
they are not current. 
 
‘Cause I am somebody who just kind of deals with things, and moves on, I, so I 
do struggle coming up with a scenario (Participant 4) 
 
‘Cause that’s what I struggled with initially, was getting my head round the fact 
that, if something’s happened I wanna talk about it straight away, I don’t wanna 
wait for a month…So, once I got my head round that then I was able to bring 
things to the group…Because it might be that you’ve already dealt with it, but 
you wanna know how to deal with it better, or next time (Participant 2) 
 
Feeling insecure/anxious. Some participants spoke about feelings of insecurity 
and anxiety in relation to group supervision. An aspect of this related to worries about 
how participants might be perceived by others, which seemed to partly relate to having 
less professional experience. 
 
And I think that’s because I’ve not been doing this before, so I’m kind of 
thinking, “what are the topics that we are going to talk about? How are people’s 
reactions in the group gonna be?” (Participant 1) 
 
I suppose maybe that you just feel you can participate more, whereas before I 
was very much like you because I was with experienced CNS’s and thinking 
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“they ain’t gonna wanna listen to what I gotta say” because, you know, they’ve, 
they had more experience and more things to say (Participant 4) 
 
 An online participant found the sessions’ structure and the generation of 
supervision questions stressful and anxiety-provoking.  
 
I personally feel that a less structured approach without set tasks would suit me 
better. A structured approach makes me feel quite anxious about the session…I 
sometimes find it more stressful trying to think of a 'question' than actually 
presenting a case (Participant 5) 
 
Discussion 
This study used a mixed methods, cross-sectional design to evaluate the 
effectiveness of SACS. Participants’ ratings indicated that supervision groups at GWH 
adhere well to SACS, suggesting participants’ accounts of supervision accurately 
pertain to the implementation of the SACS model. 
The evaluation questionnaire was used to assess the effectiveness of SACS in 
fulfilling the formative, normative and restorative aspects of supervision expected from 
the service context. Overall ratings suggested that items relating to normative functions 
were best met by the supervision groups, and items relating to restorative functions 
were least well met. It is worth noting that there was a difference between supervision 
groups in their ratings on the evaluation questionnaire, with Group A rating the 
supervision groups as meeting the three functions better than Groups B and C. Such 
differences could be due to several factors including different facilitators, how long 
group had been established for, group dynamics and group composition (bandings, 
specialities, etc.).  
A focus group and qualitative questionnaire were conducted to assess how 
SACS facilitates these supervision functions in relation to Kolb’s learning cycle and 
whether this could be improved. Participants recognised that supervision groups provide 
a space to reflect and think about cases in a way that is not otherwise available. The 
results suggested that feeling safe was a fundamental requirement to enable participants 
to engage with supervision and the associated learning. The size of the group, the 
characteristics of other members and the facilitator all contributed to the sense of safety. 
The warmth and positive regard recognised in the facilitator are hypothesised to 
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encourage change (Rogers, 1995). These aspects, while not specific to SACS, are 
nonetheless essential foundations for supervisees to engage optimally with SACS. 
Similarly, participants recognised clear benefits from attending SACS groups 
and, as a result, valued them and felt motivated to attend. Participants described ‘getting 
something out of’ SACS supervision in a way that differed to previous supervision 
experiences. The tangibility of supervision ‘outcomes’ theoretically links with the 
conceptualisation and experimentation stages of Kolb’s cycle, where some past 
experiences of supervision may have gotten ‘stuck’ at the reflecting stage. Previous 
research has found that nurses tend to focus on restorative benefits of supervision 
(Brunero & Stein-Parbury, 2008). Correspondingly, this study identified a theme of self-
care. Restorative aspects are important for maintaining staff wellbeing and reducing 
burnout, which influence the quality of care delivered (Pereira et al., 2011; Sinclair & 
Hamill, 2007). However, participants also spoke about the value of case discussion in 
improving clinical work, thus additionally identifying the formative function of 
supervision.  
The ‘mediators for supervision outcomes’ theme aligned most closely with the 
research question on how supervision functions were facilitated. For focus group 
participants, the implementation of SACS coincided with a new facilitator and both 
aspects were important mediators for participants. Many participants felt that the 
structure of SACS provided focus, allowed supervisees to know what to expect and 
prepare. Beginning supervision with a defined question encouraged supervisees to 
consider the purpose of their case presentation and think about what they wanted to 
come away with. However, some participants found the structure—in particular, 
generating a supervision question—stressful or anxiety-provoking, which, in some cases 
led to avoidance of bringing cases to supervision. Whilst there is learning to be derived 
from contributing to other people’s supervision questions, this limits the capacity to 
reflect on one’s concrete experience, as outlined in Kolb’s learning cycle. Vygotsky’s 
(1987) ‘zone of proximal development’ (ZPD) theory has previously been applied to 
supervision and outlines that learning is optimal when supervisees are reasonably 
challenged outside their comfort zone, with appropriate scaffolding to enable them to 
achieve the task (James, Milne, Marie-Blackburn, & Armstrong, 2007). Results from 
this study highlight that different supervisees within the same group are likely to have 
different ZPDs. Therefore, while supervisees will gain most from being pushed outside 
their comfort zone, those who find it challenging to produce a supervision question may 
need scaffolding to master this task. Further guidance on the SACS model (L. Charles, 
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personal communication, September 5, 2017) includes additional options for methods of 
feedback, such as “What is THE Q?” where co-supervisors support the case presenter 
towards clarity about the work to be done by suggesting questions they might choose 
facing this situation. This could provide a useful option for supervisees who need more 
practise in considering their supervision question. 
In line with previous research on group supervision (e.g. Carter et al., 2009), 
participants highlighted vicariously learning through others and hearing multiple 
perspectives as an important mediator for supervision outcomes. This was valued by 
participants, as evident from participants’ choice of feedback from SACS. This appeared 
to promote the reflecting and conceptualising parts of Kolb’s learning cycle. However, 
Gordon (2012) argues it is important to be aware of supervisees’ blind spots and take 
note of what is not brought to supervision. Therefore, supervisees who consistently 
choose the same method of feedback may benefit from being encouraged to try other 
feedback options; again, this could encourage supervisees into their ZPD. In addition, 
more active feedback methods, such as ‘show me’, could promote the experimentation 
and experiencing parts of the learning cycle. 
In relation to restorative functions, reinforcement/validation seemed to be an 
important mediator. The fact that focus group attendees had similar roles to one another 
seemed to be important for providing a sense of shared experience and validation. 
 
Limitations 
Although there was a good response rate for the evaluation questionnaire (14 of 
possible 17), no members of supervision Groups B or C attended the focus group, 
making it difficult to ascertain the cause of the difference between groups in 
questionnaire ratings. An important limitation of the qualitative data is therefore that it 
is biased towards the group that viewed supervision more favourably and may not 
represent the views of the views of other attendees. Attempts were made to overcome 
this by inviting nurses to complete qualitative questionnaires, but responses to the 
qualitative questions were brief. Nevertheless, the results provide detailed data about 
how focus group attendees felt supervision fulfilled Proctor’s functions. 
As is the case with much of the supervision literature, this evaluation was based 
solely on reports from supervisees, with no objective measure of supervision outcomes. 
Finally, this study represents an evaluation of one group supervision model, with 
no comparison to other models. 
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Implications and Recommendations 
Despite the limitations of the current study (namely, the potential bias in the 
sample and lack of comparison with other models), findings indicate that overall, 
participants felt the implementation of the SACS model was effective at facilitating 
supervision outcomes. Based on the data available in this study, several 
recommendations were made to the service. Recommendations included to continue 
with facilitated implementation of the SACS model, but to make adaptations to ease the 
stress and anxiety felt by some attendees in relation to generating supervision questions. 
This may include collaborative development of ‘group rules’, implementation of an 
additional method of feedback to support attendees with generating questions, and 
development of a leaflet for supervisees to explain the rationale behind challenging 
supervisees into their ZPD. See Table 4 for full recommendations. 
 
Conclusions 
Results from this project suggest that many participants found SACS to be 
effective at providing formative, normative and restorative functions of supervision, 
although conclusions are limited by the potential bias in the sample. The structure of 
SACS encourages movement through Kolb’s learning cycle within these functions. 
Other factors were also identified as important for effectiveness of the groups. Several 
recommendations have been made to offer potential improvements to the 
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Table 4. Recommendations to the service based on outcomes from the study  
1. Continue to allow supervision 
questions related to 
restorative functions 
Participants emphasised the importance of acknowledging the 
impact on self and to recognise the influence of work and 
home life on one another. Restorative aspects are supported in 
literature on staff wellbeing and burnout. 
2. Continue facilitated use of the 
SACS model 
Participants felt the warm, non-judgmental stance of the 
facilitator helped create a safe space and the facilitator’s 
professional background and guidance helped their learning. 
3. Introduce ‘what is THE Q’ as 
a feedback option 
Some participants found it difficult and stressful to generate 
supervision questions and this posed a barrier to their full 
participation and learning. Facilitating support with generating 
a question may provide appropriate scaffolding to enable these 
supervisees to bring cases more often. 
4. Negotiate with supervisees a 
non-threatening way of 
encouraging all supervisees to 
bring supervision questions 
Bringing a case/question to supervision allows reflection on 
concrete experience, which is part of Kolb’s learning cycle. 
For equity of learning, it is therefore important that everybody 
has opportunity to bring cases. However, some participants felt 
that allocating specific slots to individual supervisees would be 
too anxiety-provoking. Other ways of distributing supervision 
questions could be discussed and negotiated as part of the 
group rules. 
5. Consider use of supervision 
contract 
Co-creation of a contract to capture shared group ‘rules’, goals 
and expectations would make sure that the agenda is 
transparent (e.g. how often supervisees are expected to bring 
cases). This could be regularly reviewed to allow amendments.  
6. Facilitators to take active role 
in encouraging use of 
different feedback methods 
To address supervisees ‘blind spots’ and bring them into their 
ZPD, supervisees may need encouragement to try different 
methods of receiving supervision feedback if they consistently 
choose the same method.   
7. Development of an 
information leaflet for 
supervisees 
A leaflet for supervisees could contain the follow things: 
• The purpose of case reflection (to address the fact that 
some participants were unsure about the utility of 
reflecting on past cases/what constitutes ‘a good case’) 
• Examples of supervision questions (to support those who 
find it difficult to generate questions) 
• Reasons that supervisees may be invited to bring their 
own questions, or try out a different feedback method 
• Encouragement to speak to the facilitator if any 
difficulties/anxieties arise 
• Recommendation to keep ‘supervision notes journal’ to 
support development of questions prior to session 
8. Use of feedback forms Session by session feedback would allow ongoing evaluation. 
This could also measure the impact of the implementation of 
any changes. 
9. Consider the boundaries of 
restorative support and make 
staff aware of additional 
support options 
Whilst attending to self-care in supervision is important for 
supervisees, staff should be made aware of additional forms of 
support for occasions when the need for personal support is 
beyond the remit of supervision groups 
10. Further evaluation of group 
composition for all groups 
Focus group attendees reported characteristics of their 
supervision group helped them to feel safe. This included size 
(around six members), members from different teams, and no 
hierarchical roles between members. However, the 
composition of the other groups has yet to be evaluated. 
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Background: Chronic fatigue syndrome (CFS) in adolescents is associated with severe 
functional impairment. CFS is distinct from other physical health conditions in that 
individuals can experience high levels of uncertainty, stigma and disbelief from others. 
Illness perceptions in CFS are therefore of particular interest and have implications for 
treatment. However, research on illness perceptions in adolescents is limited. This study 
compared illness perceptions in adolescents with CFS with other physical health 
conditions.  
Method: Adolescents (aged 11–18) with CFS (n = 49), type 1 diabetes (n = 52) and 
juvenile idiopathic arthritis (n = 42) were recruited through NHS clinics and online and 
completed a series of questionnaires.  
Results: Adolescents with CFS differed on the perceived consequences, timeline, 
personal control, treatment control, identity and understanding dimensions of illness 
perceptions. Except identity, these dimensions were predicted by health condition even 
when accounting for age, gender, fatigue, physical functioning, anxiety and depression.  
Conclusions: Results offer preliminary evidence for the applicability of the CSM in 
adolescents, with implications for supporting adolescents with physical health 
conditions. Results suggest that psychological interventions targeting perceived control, 
understanding and identity may have particular utility for adolescents with CFS. 
 








Chronic Fatigue Syndrome (CFS), or Myalgic Encephalomyelitis (ME), is 
characterised by prolonged, debilitating and unexplained fatigue, alongside other 
symptoms that can include cognitive, sleep and musculoskeletal problems (Fukuda et 
al., 1994; NICE, 2007). The estimated prevalence of CFS in children and adolescents 
varies according to the diagnostic criteria used, ranging from 0.11–2.34% (Farmer, 
Fowler, Scourfield, & Thapar, 2004). The aetiology of CFS is not fully understood, but 
genetics, viral infection, immune and endocrine factors, stress, illness perceptions, 
psychiatric mechanisms and activity levels potentially contribute to its onset and/or 
maintenance in adolescents (Lievesley, Rimes, & Chalder, 2014). Several 
biopsychosocial theoretical models of CFS have been proposed to conceptualise how 
these factors may interact and form predisposing, precipitating and perpetuating factors 
in the development of CFS (e.g. Harvey & Wessely, 2007). 
The functional impairment associated with CFS in adolescents is considerable. 
CFS has been identified as the biggest cause of long-term sickness from school 
(Crawley, Emond, & Sterne, 2011; Dowsett & Colby, 1997), with one study reporting 
an average of one year absence from school in adolescents with CFS (Rangel, Garralda, 
Levin, & Roberts, 2000). Adolescents with CFS also report functional impairment for 
carrying out activities at home (Garralda & Rangel, 2004) and impaired social 
functioning (Rangel et al., 2000). The impact to the individual is therefore substantial. 
As there is no definitive, objective test of its presence, CFS can only be 
diagnosed after exhaustive physical investigations and psychiatric assessment to rule 
other potential causes of fatigue such as anaemia, hypothyroidism and primary 
depression (Afari & Buchwald, 2003; Devanur & Kerr, 2006). This can lead to certain 
psychosocial challenges specific to the illness experience in CFS. Qualitative analysis 
of interviews with adolescents with CFS identified a number of themes around 
uncertainty about: the future, the validity of CFS (experiencing disbelief and distrust 
from family, friends and teachers) and about how to explain it to others (Fisher & 
Crawley, 2012). Several other studies have acknowledged the stigma associated with 
CFS, including a general ‘lack of permission’ from society to be ill in the absence of 
recognised disease. (Nettleton, 2006). Trainee medics have been found to express 
negative attitudes towards individuals with CFS (Stenhoff, Sadreddini, Peters, & 
Wearden, 2015) and over a third of adult CFS patients report that a physician has failed 
to legitimise or acknowledge the reality of their experience (Lehman, Lehman, 
Hemphill, Mandel, & Cooper, 2002). Perceived stigma has been rated as higher in CFS 
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than in other physical health conditions, including other “medically unexplained” 
conditions (Looper & Kirmayer, 2004). Thus, the illness experience in CFS is 
subjectively different to other physical health conditions. 
The Common-Sense Model of illness representation (CSM; Diefenbach & 
Leventhal, 1996; see Figure 1) proposes that individuals hold implicit cognitive and 
emotional perceptions of their illness (Hagger & Orbell, 2003). These perceptions are 
influenced by somatic experiences, social and cultural beliefs, and knowledge derived 
from others, including professionals (Petrie & Weinman, 2006). Cognitive illness 
perceptions are made up of: illness identity (label given and symptoms attributed to the 
illness by the individual), perceived cause of the illness, timeline (how long the 
individual believes the illness will last), beliefs about controllability or curability, and 
beliefs about the illness’s consequences. The illness perception questionnaire (IPQ; 
Weinman, Petrie, Moss-Morris, & Horne, 1996), revised illness perception 
questionnaire (IPQ-R; Moss-Morris et al., 2002) and brief illness perception 
questionnaire (BIPQ; Broadbent, Petrie, Main, & Weinman, 2006) have all been devised 
to measure the components of cognitive and emotional illness perceptions.  
Illness perceptions are important because they guide coping responses and 
illness management, which in turn influences medical, psychological and behavioural 
outcomes (Petrie, Jago, & Devcich, 2007). Several studies have demonstrated that 
negative illness perceptions (e.g. beliefs about more symptoms being associated with 
the condition, more severe consequences, longer timeline) are associated with increased 
disability, slower recovery and poorer quality of life, independent of initial medical 
severity of the condition (Hagger & Orbell, 2003; Petrie & Weinman, 2006). This 
finding has been supported in adults with a wide range of physical health conditions 
including chronic pain (Costa, Vale, Sobral, & Graca Pereira, 2015), COPD (Zoeckler, 
Kenn, Kuehl, Stenzel, & Rief, 2014), congenital heart disease (Schoormans et al., 
2014), chronic kidney disease (Knowles, Swan, Salzberg, Castle, & Langham, 2014), 
asthma (Kaptein, Klok, Moss-Morris, & Brand, 2010) diabetes (Broadbent, Donkin, & 
Stroh, 2011) and CFS (Heijmans, 1998; Moss-Morris, Petrie, & Weinman, 1996). In 
line with the CSM, there is evidence that illness perceptions in CFS are distinct in 
comparison to other physical health conditions; for example, greater identity and 
consequences perceptions, but more acute timelines have been observed in adults with 
CFS compared to diabetes, chronic pain (Weinman et al., 1996) and rheumatoid arthritis 
(Moss-Morris & Chalder, 2003), even when physical functioning is comparable (Moss-
Morris & Chalder, 2003). Such findings indicate that illness perceptions may be of 
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particular relevance in CFS and may be related to the distinct illness experience. As 
illness perceptions are associated with adaptive outcomes in CFS (Heijmans, 1998; 
Moss-Morris et al., 1996), they could be conceptualised as a perpetuating factor within 
a biopsychosocial framework of CFS—having the potential to contribute to the 
maintenance, or potential worsening of, fatigue and other physical symptoms (De 
Gucht, Garcia, den Engelsman & Maes, 2017). As such, they could hold potential for 
refining and improving interventions, and for reducing the distressing impact of CFS. 
Cognitive-behavioural therapy (CBT) is a treatment recommended by NICE (2007) for 
CFS. CBT aims to address cognitive and behavioural factors proposed to be 
perpetuating symptoms, such as ‘boom-and-bust’ activity and unhelpful beliefs related 
to CFS (Loades & Chalder, 2017). As illness perceptions could be a perpetuating 
cognitive factor, it may be that CBT interventions need to target these to be more 
effective (Wiborg, Knoop, Frank, & Bleijenberg, 2012). The CSM therefore has many 
implications for biopsychosocial assessment and intervention; however, there has been 
little investigation of illness perceptions in adolescents, so the extent to which the CSM 
is applicable in adolescents with physical health conditions remains to be tested. 
 
Figure 1. The Common-Sense Model of illness representation. Adapted from 
Diefenbach and Leventhal (1996). 
 
One study focused on illness perceptions in young people with CFS (Gray & 
Rutter, 2007). Using the IPQ-R, young people were found to have identifiable 
perceptions of their CFS, which are linked to coping and outcomes. However, as there 
was no comparison group included, it is unclear if these findings are unique to young 
people with CFS or generalisable across physical health conditions. There are number 
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findings. Firstly, the age of participants was heavily skewed; only two of the 85 
participants were under 14 years old, whilst 61 participants were aged between 17–25. 
Thus, a large proportion of the sample were young adults and findings are therefore not 
necessarily representative of adolescents with CFS. Gender was also skewed, with only 
five male participants. Although CFS is more common in females, prevalence studies 
indicate that 25% of children and young people with CFS are male  (Lievesley et al., 
2014), meaning males were underrepresented in the study. Further, as participants were 
recruited online via a self-help group, participants’ diagnoses could not be verified. This 
method of recruitment also means that all participants were employing a particular 
coping strategy—again, limiting the generalisability of the findings. Further, depression 
was not measured in this study, despite a high comorbidity; at least 30% of young 
people with CFS are believed to have probable depression (Bould, Collin, Lewis, 
Rimes, & Crawley, 2013; Loades, Rimes, Ali, Lievesley, & Chalder, 2017), with 
depression scores found to be higher in those with CFS compared to arthritis (Brace,  
Smith, McCauley & Sherry, 2000). The tendency to make global, stable, internal 
attributions when depressed (Gladstone & Kaslow, 1995) could plausibly be linked to 
more negative illness perceptions so is an important variable to consider. 
Research in adults, including those with CFS, has provided support for the 
CSM. However, it is less clear if the CSM assumptions hold true in adolescent 
populations. Given the developmental differences between adults and adolescents, 
differences in power dynamics and routes into services, it is not sufficient to generalise 
research from adults. Testing the applicability of the CSM in adolescents has 
implications for improving service provision, including psychological treatments.  
The current study used a between-groups, cross-sectional design to compare 
illness perceptions across adolescents with CFS, juvenile idiopathic arthritis (JIA) and 
type 1 diabetes (T1D). JIA was chosen as a comparison group because it shares some 
similarities with CFS. It is idiopathic (like CFS) and there is an overlap in the nature of 
symptoms in CFS and JIA, with joint pain, stiffness and restricted movement featuring 
in both conditions (NICE, 2015). However, in JIA there are observable physical markers 
that facilitate diagnosis, such as swelling and restricted movement in joints (Bailey, 
2014) and it is associated with less fatigue (Ali, Matcham, Irving & Chalder, 2017). 
T1D was chosen as a control group, as it is a physical health conditions with an 
identified physical cause and can be diagnosed with simple tests (NICE, 2015). Both 
JIA and T1D are associated with less stigma than CFS. Fatigue and physical functioning 
were measured to test to what degree illness perceptions could be accounted for by 
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these variables. Given the higher prevalence of depression in CFS than other physical 
health conditions (Ali et al., 2017), and the possible relationship with cognitive 
perceptions, depression was also measured. Similarly, anxiety was measured to test if 




1. Are illness perceptions different in adolescents with CFS, compared to 
adolescents with other physical health conditions? 
2. Are illness perceptions different in adolescents with CFS, compared to 
adolescents with other physical health conditions when accounting for 
fatigue, physical functioning, depression and anxiety? 
Hypotheses 
Based on the CSM and existing research in adults, we predicted that illness 
perceptions will differ in adolescents with CFS compared to JIA and T1D. Specific 
predictions based on Moss-Morris and Chalder’s (2003) and Weinman et al.’s (1996) 
findings in adults with CFS, arthritis and diabetes are as follows: 
1. Adolescents with CFS will report higher scores on identity, consequences 
and emotional responses subscales than adolescents with JIA and T1D. 
2. Adolescents with CFS will report a less chronic timeline than adolescents 
with JIA and T1D 
3. These differences in illness perceptions will remain when controlling for 
fatigue, physical functioning, depression and anxiety 
The following predictions are also made regarding other variables: 
4. In line with the defining characteristics of CFS and previous comparisons of 
adults with CFS and arthritis (Ali et al. 2017), it is predicted that adolescents 
with CFS will report higher levels of fatigue compared to adolescents with 
JIA or T1D.  
5. Based on illness characteristics and comparison of adults with CFS and 
arthritis (Moss-Morris & Chalder, 2003) it is predicted that adolescents with 
CFS will report similar levels of physical functioning to adolescents with 
JIA, but lower than T1D.  
6. Based on findings regarding the prevalence of depression in different 
physical health conditions (Ali et al., 2017; Bould et al. 2013), it is predicted 
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that adolescents with CFS will report higher depression scores than 




Participants were recruited over 18 months between 2016–2018. CFS 
participants were age 12–18 years. T1D and JIA participants were age 11–17 years. 
Participants were required to be able to complete written questionnaires. 
Of the participants recruited through clinics, 10 were excluded from analysis due 
to incomplete data (CFS=7; T1D=3). With online recruitment, a total of 92 responses 
were recorded. Of these, 15 were screened out for being outside the eligible age range, 
44 did not progress past the information sheet and three were excluded due to 
incompletion of the measures. Of the 30 participants who completed the study online, 
16 stated they were from UK; eight from the USA; two from Canada; and one from 
Egypt, South Africa, Australia and Germany. 
The final sample consisted of 130 participants, including 82 females (63%) and 
48 males (37%). Mean age was 14.54 years (range 11–18; SD 1.91). See Table 2 for 
descriptive characteristics of sample and Figure 2 for flow diagram of recruitment. 
 



















































Clinic-recruited CFS participants were recruited from a specialist paediatric CFS 
team at the Royal United Hospital, Bath as part of a larger study. Participants were 
recruited following diagnosis, but prior to receiving intervention from the service. CFS 
diagnoses were confirmed according to NICE (2007) diagnostic criteria. Consent 
procedures and questionnaires were completed electronically via REDCAP, or pen-and-
paper, depending on participant preference. Participants <16 years were required to gain 
consent from a parent / carer.   
Clinic-recruited T1D and JIA participants were recruited through Bristol 
Children’s Hospital. Diagnoses were confirmed by medical records prior to participation 
in the study. Eligible participants were invited to take part by researchers at outpatient 
clinic appointments. Consent procedures and questionnaires were completed 
electronically using the Qualtrics platform, administered on an iPad. Participants <16 
years were required to gain consent from a parent / carer. Participants were left alone to 
complete the measures.  
Participants were also recruited online; links to the online study (including 
online information sheets and consent forms) were posted in support groups on social 
media platforms and advertised online by National charities. Diagnoses were self-
reported among these participants. 
 
 
























Demographic information (age, gender, and country of residence for participants 
recruited online) was collected via self-report questions. For clinic-recruited CFS 
participants, medical comorbidities were recorded by the research team. These were 
screened for JIA and T1D. For all other participants, physical health conditions were 
self-reported via the online questionnaire. 
Internal consistency for measures and subscales was calculated using 
Cronbach’s alphas for each of the three conditions. See Table 1.  
Illness perceptions. - Brief Illness Perception Questionnaire (BIPQ; Broadbent 
et al., 2006): a nine-item measure of cognitive and emotional perceptions of illness, 
with each measuring a different subscale. Eight items are rated on a 0–10 response 
scale: consequences (effect on life), timeline (expected duration), personal control 
(sense of control), treatment control (expected treatment effectiveness), identity 
(number and intensity of symptoms), concern, understanding and emotional response. 
The ninth item—cause—is open-ended, asking participants to list the three most 
important causal factors in their illness. The BIPQ has good to moderate concurrent 
validity with the longer IPQ-R (Pearson correlations between subscales: r=.33–.63, all 
p<.001; Broadbent et al., 2006), and has been found to have good validity and reliability 
in adults with a variety of illnesses (see Broadbent et al., 2006). The BIPQ has been 
previously used in adolescents with different physical health conditions (e.g. McGrady 
et al., 2010; Michel, Taylor, Absolom, & Eiser, 2010), but formal psychometric 
properties have not been reported for this age group.  
Anxiety and depression. - Revised Children’s Anxiety and Depression Scale 
(RCADS; Chorpita, Ebesutani, & Spence, 2011). This 47-item questionnaire measures: 
separation anxiety, social phobia, generalised anxiety, panic, obsessive compulsive, and 
depression. Items are rated on a four-point Likert-scale from 0=never to 3=always. Total 
anxiety and depression scores were used in this study. The RCADS has been found to 
have favourable construct and factorial validity (Chorpita, Moffitt, & Gray, 2005). 
Physical Functioning. - 10-item physical functioning subscale of the 36-Item 
Short Form Health Survey (SF-36; Ware Jr & Sherbourne, 1992). Items are rated on a 
three-point scale from 1–3 (Ware Jr, Snow, Kosinski, & Gandek, 1993). Higher score 
indicates better physical functioning. High internal reliability of the subscale has been 
found in adults with CFS (Cronbach’s alpha=.90) and convergent validity is also good 
(Buchwald, Pearlman, Umali, Schmaling, & Katon, 1996). The physical functioning 
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subscale has previously been used in adolescents with CFS (e.g. Stulemeijer, de Jong, 
Fiselier, Hoogveld, & Bleijenberg, 2004) but has yet to be adequately validated. 
Fatigue. - 11-item Chalder Fatigue Questionnaire (CFQ; Chalder et al., 1993). 
This measure consists of two subscales: physical and mental fatigue. Each item has four 
response options: “less than usual”, “no more than usual”, “more than usual” and “much 
more than usual”. The measure has been validated in both clinical and non-clinical adult 
samples (Cella & Chalder, 2010) and has been used extensively in research with 
adolescents (e.g. Bould et al., 2013; Crawley & Sterne, 2009). Scoring can take the 
form of a bimodal system, or a Likert system. In this study, Likert scoring was used, 
with each item scored 0–3. High internal consistency has been found for the scale with 
Cronbach’s alpha=0.88–0.90 (Cella & Chalder, 2010).  
 

























CFS .85 .96 .96 .93 .80 .84 .89 
JIA .90 .95 .96 .94 .53 .84 .82 
T1D .93 .97 .98 .90 .66 .92 .89 
 
Involvement of People with Personal Experience 
A draft of the participant information sheets and consent forms were given to a 
young person’s advisory group at University Hospitals Bristol NHS Foundation Trust. 
Amendments were made to the content and layout based on their feedback. 
 
Ethics 
The data collection for T1D and JIA participants was approved by NHS Wales 
Research Ethics Committee 3 (reference: 16/WA/0378) and University of Bath Ethics 
Committee (reference 17-019). The data collection for CFS participants was approved 
by NHS Frenchay Ethics Committee (reference 16/SW/0136) and University of Bath 
Ethics Committee (reference 16-203). See Appendix F. 
 
Data Analysis 
Power calculations. A-priori power calculations were made using G*power to 
establish necessary sample size. The BIPQ has not previously been used to compare 
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illness perceptions in CFS and other conditions, so instead effect sizes were based on a 
study using the BIPQ to compare CFS participants with non-CFS fatigued participants 
(De Gucht, Garcia, den Engelsman, & Maes, 2016). See Appendix G. Post-hoc power 
calculations were also carried out, which suggested that the study was sufficiently 
powered. 
Exclusions and missing data. Two online participants were excluded from 
analysis for having two of the physical health conditions of interest in this study. A 
further nine participants were excluded for missing data (CFS=7; T1D=2); all with ≥1 
questionnaire missing. Where cases had ≤5% of data missing, (n=2; both CFS) mean 
values were inputted for missing items (Roth, 1994). No items were missing from the 
BIPQ. 
Statistical analyses. All analyses were carried out using SPSS version 24. First, 
the three conditions (CFS, JIA and T1D) were compared on demographic characteristics 
and potential predictor variables. Data screening indicated that variables largely did not 
meet assumptions of normality and homogeneity of variance, so non-parametric tests 
were used. All comparisons were made using two-tailed tests, with a Holm-Bonferroni 
corrected alpha. This controls the inflation of Type 1 error rate, while maintaining 
power (Ludbrook, 1998). Pearson chi-square was used for categorical variables (gender) 
and Kruskal-Wallis was used for continuous variables (age, physical fatigue, mental 
fatigue, physical health subscale, depression score and anxiety score). The data file was 
then split by condition and the same variables were examined within conditions, to 
compare clinic-recruited and online-recruited participants. Chi-square was used for 
gender and Mann-Whitney for the six continuous variables.  
Qualitative responses for the cause subscale of the BIPQ were coded by (a) 
psychological (including stress or overwork); (b) risk factors (including genetics or 
diet); (c) immune causes (including virus); (d) chance (including an accident or bad 
luck); or (e) physical over-activity. Blank responses or “I don’t know” responses were 
not coded. As expected and observed counts were low within categories, percentages 
were compared. Conditions were then compared on each of the eight continuous-data 
BIPQ subscales using a series of Kruskall-Wallis tests. In the next stage of the analysis, 
a series of multiple hierarchical regressions were conducted with BIPQ subscales as the 
dependent variables. As the outcome variables showed indicators of heteroscedasticity 
and non-normally-distributed residuals, bootstrapping procedures were applied, with 
1,000 trials. Bootstrapping is a robust statistical technique that does not rely on these 
assumptions (Wright, London, & Field, 2011). Independent variables were entered in 
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three blocks using the entry method. Gender and age were entered in the first block; 
physical fatigue, mental fatigue, physical functioning, depression score and anxiety 
score in the second block; and condition in the third block. Condition was dummy 
coded using T1D as the reference group. 
As a further, exploratory analysis, illness perceptions were compared between 
depressed and non-depressed participants. This is presented as supplementary material 
(Appendix H). 
Results 
The three conditions (CFS=36; JIA=42; T1D=52) were compared across 
predictor variables. There was a significant effect of condition on gender, (χ2(2, 
N=130)=9.05, p=.011), age (χ2(2, N=130)=9.04, p=.011), physical fatigue (χ2(2, 
N=130)=52.04, p<.001), mental fatigue (χ2(2, N=130)=46.86, p<.001), physical 
functioning (χ2(2, N=130)=30.97, p<.001) and depression score (χ2(2, N=130)=17.30, 
p<.001) (see Table 2). There was no significant effect of condition on anxiety score. The 
difference in gender distribution between groups was followed-up with inspection of 
standardised residuals, which indicated that there was a significantly higher proportion 
of females in JIA group than expected. Standardised residuals were not significant in 
CFS or T1D groups. Remaining significant differences were followed up with Dunn-
Bonferroni pairwise comparisons. CFS participants were significantly older than JIA 
participants (p=.008). There were no other differences in age. Physical fatigue was 
higher in CFS than both JIA (p<.001) and T1D (p<.001). Mental fatigue was also 
significantly higher in CFS than JIA (p<.001) and T1D (p<.001). Physical functioning 
was comparable across CFS and JIA participants, with T1D participants demonstrating 
significantly higher physical functioning than both (p<.001). Depression was 
significantly higher in CFS participants than JIA (p=.002) and T1D participants 
(p<.001). 
No significant differences were found in predictor variables between online and 
clinic-recruited participants, except for physical functioning in JIA participants. JIA 
clinic recruited participants had higher physical health score (mean rank 25) than those 
recruited online (mean rank 16), indicating that those recruited from clinic had better 
overall health (p=.033). This did not remain significant when using the Holm-
Bonferroni correction. 
Between-group comparisons on BIPQ subscales identified significant 
differences in consequences (χ2(2, N=130) =17.04, p<.001), timeline (χ2(2, 
N=130)=49.58, p<.001), personal control (χ2(2, N=130)=35.39, p<.001), treatment 
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control (χ2(2, N=130)=31.25, p<.001), and understanding subscales (χ2(2, 
N=130)=11.20, p<.001). There were no significant differences in identity, concern or 
emotional response subscales. Pairwise comparisons indicated that illness consequences 
were rated as being greater in CFS participants than in JIA (p<.001) or T1D participants 
(p=.002). T1D participants rated their condition as having a longer timeline than JIA 
and CFS participants (p<.001), with JIA rating these items higher than CFS participants 
(p=.01). T1D participants also perceived more treatment control than JIA participants 
(p=.015) and CFS participants (p<.001), with JIA perceiving more treatment control 
than CFS participants (p=.018). T1D participants rated themselves as having more 
personal control than both JIA (p<.001) and CFS participants (p<.001), who did not 
significantly differ. Finally, understanding was significantly lower in CFS participants 
than T1D participants (p=.003); neither differed from JIA. See Table 3 for group 
comparisons. 
Table 2. Sample characteristics and between-condition comparisons 
 CFS 
(n = 37) 
 JIA 
(n = 42) 
 T1D 
(n = 52) 
P value 
 n %  n %  n %  
Male 18 (50%)  8 (19%)  22 (42.3%) .011* 
Female 18 (50%)  34 (81%)  30 (57.7%)  
 M SD  M SD  M SD  
Age 15.22 a (1.69)  13.86 b (1.95)  14.58 a,b (1.85) .011* 
Physical fatigue 17.17 a (3.11)  10.38 b (4.26)  9.12 b (4.91) <.001* 
Mental fatigue 8.31 a (2.38)  4.88 b (1.80)  4.31 b (2.22) <.001* 
Physical functioning 20.47 a (5.37)  21.98 a (5.86)  26.52 b (3.93) <.001* 
RCADS Depression 15.78 a (5.30)  10.52 b (5.99)  10.23 b (7.36) <.001* 
RCADS Anxiety 37.44 a (20.99)  30.88 a (18.12)  32.33 a (23.97) .354 
RCADS, Revised child anxiety and depression scale; M, mean; SD, standard deviation 
Shared superscripts denote no significant differences 
*significant using Holm-Bonferroni adjusted p-values 
 
Comparison of categorised responses for the cause subscale showed CFS 
participants were most likely to attribute cause of illness to psychological causes (55% 
of responses), followed by immune causes (27%). In contrast, JIA and T1D participants 
were most likely to attribute cause of illness to risk factors (49 and 63%, respectively), 
followed by immune causes (27 and 18% respectively), as well as chance in T1D (also 
18%). 
ILLNESS PERCEPTIONS IN ADOLESCENTS WITH CFS 
 
79 
Table 3. Between-condition comparisons on BIPQ subscales 
 CFS 
n = 37 
 JIA 
n = 42 
 T1D 
n = 52 
 
 M SD  M SD  M SD P value 
Consequences 
 
7.67 a (1.62)  5.93 b  (2.08)  6.15 b  (2.15) <.001* 
Timeline 6.03 a (1.78)  7.50 b  (2.58)  9.38 c  (1.59) <.001* 
Personal control 2.92 a (2.01)  3.95 a  (2.16)  5.87 b  (1.96) <.001* 
Treatment control 5.22 a (2.21)  6.88 b (2.26)  8.15 c  (2.36) <.001* 
Identity 7.06 a (1.90)  5.90 a (2.22)  6.04 a  (2.36) .078 
Concern 6.14 a (2.40)  5.74 a  (2.43)  5.19 a  (2.82) .263 
Understanding 6.81 a (1.98)  7.64 a, b  (2.54)  8.19 b  (1.93) .004* 
Emotional response 6.56 a (2.68)  6.43 a  (2.67)  6.04 a  (2.92) .679 
Shared superscripts denote no significant differences. 




Bootstrapped multiple regressions demonstrated that, after controlling for age 
and gender, predictor variables (mental fatigue, physical fatigue, physical functioning, 
depression and anxiety) made a significant improvement to the amount of variance 
explained when consequences, timeline, personal control, treatment control, identity and 
emotional response where entered as the outcome variable. Entering condition at step 3 
significantly improved the model for timeline, personal control and treatment control as 
outcome variables. JIA vs T1D was a significant predictor in the consequences 
dimension, and CFS vs T1D was a significant predictor in the understanding dimension. 
The final models at step 3 explained 36.7% of the total variance in the timeline 
dimension, 31.9% of variance in perceived personal control and 25.6% of variance in 
perceived treatment control. See Table 4. 
 
  






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































This study investigated the assumption, based on the CSM, that illness 
perceptions differ across adolescents with different physical health conditions. The 
results revealed significant differences across adolescents with CFS, JIA and T1D. 
Adolescents with CFS perceived greater consequences, a less chronic timeline, and 
lower treatment control than adolescents with JIA or T1D, and less understanding of 
their condition than adolescents with T1D. Adolescents with CFS and JIA reported less 
personal control over their illness than adolescents with T1D. With the exception of the 
consequences subscale, these findings remained consistent when controlling for age, 
gender, fatigue, physical functioning, anxiety and depression. As predicted, CFS 
participants reported significantly higher physical and mental fatigue than JIA and T1D 
participants. Comparable levels of physical functioning were found between CFS and 
JIA participants using the SF-36 subscale, while T1D participants reported higher 
physical functioning. Depression scores were higher among CFS participants compared 
to JIA and T1D. No significant differences were found in anxiety.  
The finding that illness perceptions differed across conditions supports the 
overall hypothesis that illness perceptions in adolescents with CFS are distinct from 
other physical health conditions. This is consistent with research with adults (Dickson, 
Toft, & O'Carroll, 2009; Moss-Morris & Chalder, 2003) and provides preliminary 
evidence for the validity of the CSM in adolescents with physical health conditions. As 
predicted, higher consequences were reported in CFS participants—attesting to the 
severe functional impairment associated with CFS in adolescence (Crawley et al., 2011; 
Garralda & Rangel, 2004). This is also consistent with research with adults (Moss-
Morris & Chalder, 2003; Wiborg et al., 2012). (Butler, Chalder, & Wessely, 2001; Moss-
Morris & Chalder, 2003)Inconsistent with the prediction, and in contrast to research 
with adults, no differences in illness identity were found across conditions. Thus, 
adolescents with CFS reported the condition impacts their life more severely than JIA 
and T1D, despite reporting a similar number and severity of symptoms and despite 
similar levels of physical functioning to JIA participants. 
In contrast to prediction, no difference was found in ratings of emotional 
responses to illness across conditions. This is somewhat surprising given the uncertainty 
associated with CFS, participants’ ratings of the severe impact on life and the finding 
that depression scores were higher in participants with CFS. Given that CFS 
participants were most likely to attribute the cause of their illness to psychological 
factors, it is possible that adolescents with CFS are more likely to view CFS as a 
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consequence of psychological difficulties, rather than the other way around. However, 
qualitative interviews with adolescents with CFS and depression found that most felt 
CFS predated depression (Taylor, Loades, Brigden, Collin, & Crawley, 2017). It is also 
possible the higher depression scores in CFS participants are reflective of the overlap in 
symptoms. The relationship between mood, CFS and illness perceptions warrants 
further research.  
The finding that CFS was associated with lower perceived control suggests that 
there is an aspect of having CFS, not accounted for by fatigue and physical functioning, 
that is influencing this illness perception. A possible explanation is that the lack of 
established aetiology of CFS, lack of clear medical treatment, and the associated 
uncertainty may contribute to participants’ diminished sense of control. According to 
the CSM, these differences in illness perceptions have implications for coping responses 
and illness management, as well as medical and psychological outcomes (Petrie et al., 
2007). Meta-analyses have found that higher perceived control is consistently associated 
with better outcomes, such as greater physical functioning, role functioning and 
psychological wellbeing, and lower distress and disease state (Hagger, Koch, 
Chatzisarantis, & Orbell, 2017; Hagger & Orbell, 2003). Higher perceived control is 
also associated with cognitive reappraisal, problem-focused and social support-seeking 
coping strategies, whereas lower perceived control is associated with avoidance. A 
systematic review of interventions targeting illness perceptions found that perceived 
control most frequently shifted (Broadbent et al., 2015), suggesting that perceived 
control is amenable to change. Indeed, an increased sense of control has been 
hypothesised as being an important mediator for treatment outcomes in CBT for CFS 
(Wiborg et al., 2012). 
The perception of a less chronic timeline in CFS participants compared with JIA 
and T1D supports the hypothesis and is consistent with previous research with adults 
(Dickson et al., 2009; Moss-Morris & Chalder, 2003). This is suggestive of 
beliefs/hopes for recovery in adolescents with CFS, but as perceived control is low, this 
indicates that participants are attributing their anticipated recovery to factors outside of 
their control. Findings from wider literature on the relationship between perceived 
timeline and coping/outcomes is mixed. While some have found reported chronic 
timeline to be associated with worse outcomes (Broadbent et al., 2015; Hagger & 
Orbell, 2003), Hagger et al. (2017) found some evidence that reported chronic timeline 
had an indirect effect of higher physical functioning, social functioning and wellbeing, 
with lower distress and disease state, mediated by problem-focused generic coping. It is 
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possible that in some cases, perceiving a health condition as less chronic reduces 
motivation to engage in adjustment to the condition. Future research would benefit from 
examining these relationships specifically in adolescents with CFS.      
 
Limitations 
There are several limitations to this study, which should be accounted for in the 
interpretation of the findings. Participants were recruited from clinics using convenience 
sampling, which limits generalisability. As these participants were accessing specialist 
services, it is not clear to what extent these findings generalise to participants treated in 
primary care, or too unwell to access specialist services. It does, however, allow 
verification of diagnoses, whereas diagnoses in online-recruited participants were self-
reported and not clinically verified. This is of particular significance for the CFS 
participant who took part online, given the exhaustive and specialist testing required to 
diagnose CFS. In addition, participants recruited from services and online may be 
utilising different copings strategies, with implications for illness perceptions. Thus, the 
results could be biased towards individuals with certain illness perceptions, coping 
strategies and physical health outcomes. The finding of no differences between online 
and clinic-recruited T1D and JIA participants on predictor variables is encouraging with 
regards to generalisability, but this will need to be further investigated in the future. 
There was on overrepresentation of females in the T1D and JIA samples in 
comparison to other studies (Packham & Hall, 2002; Soltesz, Patterson, Dahlquist, & 
Group, 2007). In contrast, the gender distribution in the CFS sample was equal, whereas 
CFS is believed to affect females disproportionately by 3:1 (Lievesley et al., 2014). This 
raises questions regarding the representativeness of the samples.  
The eligible age range for participants varied slightly across groups, which is 
partly a result of differences in access between the specialist services. Groups were 
unmatched on demographic factors, including age, where CFS participants were older 
than JIA participants. However differences in demographic factors were controlled for 
in the regression analyses. Despite the older age of CFS participants, younger 
adolescents were better represented in the current study than in Gray and Rutter’s 
(2007) research on young people with CFS, thus, providing preliminary evidence for 
individuals in this age group. 
A further limitation is that duration of illness was not accounted for in this study, 
which could have differed across conditions. This is an important variable to consider in 
future research, as the CSM proposes that longer illness duration is associated with 
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more opportunity for appraisal of coping and illness management, which may lead to 
amendment of illness perceptions. 
Although the measures used in this study have previously been used in research 
with adolescents, the CFQ and SF-36 physical functioning subscale have yet to be 
adequately validated in the populations in this study. Cronbach alphas indicate good 
internal consistency, with the exception of mental fatigue, which was problematic in the 
JIA and T1D participants. 
Finally, it is important to remember the complexity of the relationship between 
physical and psychological variables when conducting studies in those with physical 
health conditions; according to the CSM, physical variables can be both illness 
outcomes and the internal stimuli that contribute to illness perceptions. Thus, there is 
not a simple linear causality when studying the role of psychological variables. 
 
Implications 
The preliminary support from this study for the validity of the CSM in 
adolescents suggests that cognitive illness perceptions are important to consider as part 
of a biopsychosocial assessment, formulation and treatment of adolescents with physical 
health conditions.  
CBT is the evidence-based treatment recommended by NICE (2007) to improve 
outcomes in adolescents with CFS; evidence shows that with specialist treatment, up to 
two thirds of young people recover from CFS (Lloyd, Chalder, & Rimes, 2012; Nijhof, 
Bleijenberg, Uiterwaal, Kimpen, & van de Putte, 2012; Nijhof et al., 2013). However, 
the precise mechanisms of change in CBT for CFS are unclear; a better understanding 
of these mechanisms may improve the efficacy. Illness perceptions have previously 
been identified as an important target for CBT for adults with CFS (Wiborg et al., 2012) 
and the findings from this study provide some evidence for specific illness perceptions 
to target in adolescents with CFS. The lower perceived control found in CFS 
participants is likely to impact engagement with CBT; CBT requires collaborative 
engagement and a sense of self-efficacy; it is necessary that adolescents believe the 
treatment being offered can support them to develop the skills required to bring about 
change (Stallard, 2005). This suggests that psychoeducation, socialisation to CBT as a 
form of treatment (and its effectiveness) and interventions aimed at improving self-
efficacy may be important components to be delivered early in contact with services. 
Similarly, while the lower perceived understanding in CFS participants reflects a poorer 
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medical understanding of the aetiology, this highlights the importance of giving service 
users the most up-to-date knowledge and research that we have access to. 
 
Future Research 
The inclusion of participant youCFS sample in this study contained a higher 
proportion of young adolescents compared to Gray and Rutter’s (2007) study and no 
participants over 18 years Future research would benefit from recruitment of larger 
samples from a range of settings to increase generalisability. Longitudinal designs 
would allow investigation of the relationship between illness perceptions, coping 
strategies and outcomes over time. Intervention studies for adolescents with CFS should 
consider including a measure of illness perceptions to track changes and their 
relationship to other treatment outcomes. 
 
Conclusions 
This study found that adolescents with CFS differ in their illness perceptions 
compared to adolescents with other physical health conditions, thus providing initial 
evidence for the applicability of CSM in this population. In particular, CFS participants 
reported lower perceived control, a less chronic timeline and less understanding of their 
illness. This is likely to have implications for the coping strategies used and the 
readiness to engage with evidence-based treatments. Interventions should consider 
explicitly targeting these perceptions to optimise outcomes. Future research should 
monitor the impact of intervention on illness perceptions. 
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Chronic Fatigue Syndrome (CFS) is a physical health condition characterised by 
prolonged, debilitating and unexplained fatigue, alongside other symptoms than can 
include cognitive, sleep and musculoskeletal problems. The cause of CFS is not fully 
understood, but genetic factors, viral infection, immune and endocrine factors, stress, 
illness perceptions, psychiatric mechanisms and activity levels have all been named as 
potentially being involved in its onset and maintenance in adolescents. There is 
considerable functional impairment associated with CFS in adolescence; for example, it 
is the biggest cause of long term sickness from school. 
As CFS is not well understood, it can only be diagnosed after exhaustive tests to 
rule other potential causes out. As a result, adolescents with CFS report feeling 
disbelieved about their condition, uncertainty around their future and concerns about 
how to explain it to others. Research has identified that individuals with CFS often feel 
stigmatised by others, including health professionals. The experience of having CFS is 
therefore different to a lot of other physical health conditions. 
The ‘common-sense model’ of illness representations proposes that individuals 
have cognitive and emotional perceptions about their illness, based on their illness 
experience, which encompasses somatic sensations, personal and social beliefs and 
information from others. These illness perceptions guide coping strategies and illness 
management, and influence medical, psychological and behavioural outcomes. More 
negative illness perceptions are associated with increased disability, slower recovery 
and poorer quality of life. The common-sense model has been tested in adults with a 
wide range of physical health conditions, but its testing on adolescents has been very 
limited. 
Due to the distinct illness experience in CFS, illness perceptions are of particular 
interest. One study found that adults with CFS had more negative perceptions of 
identity and consequences than adults with rheumatoid arthritis, despite comparable 
levels of disability. It has been suggested that illness perceptions need to be targeted 
within CBT for CFS. However, illness perceptions in adolescents with CFS have not 






The aim of this study was to test the applicability of the common-sense model in 
adolescents by finding out if illness perceptions in adolescents with CFS were different 
to illness perceptions in adolescents with Juvenile Idiopathic Arthritis (JIA) and Type 1 
Diabetes (T1D). JIA shares some features with CFS (pain, physical fatigue, unknown 
cause), but it also easier to diagnose and is associated with less stigma. T1D has an 
identified physical cause and can be diagnosed with a simple test.  
 
Method 
Adolescents (aged 11–18) were recruited with either CFS, JIA or T1D. 
Adolescents were asked to fill in questionnaires about their illness perceptions, anxiety, 
depression, fatigue and physical functioning. Illness perceptions were measured using 
the Brief Illness Perceptions Questionnaire (BIPQ) which consists of nine components: 
consequences (perceived effect on life), timeline (expected duration), sense of personal 
control, treatment control (expected treatment effectiveness), identity (number and 
intensity of symptoms), concern, understanding, emotional response and cause. 
Scores on each of the illness perceptions scales were then compared. Final analysis 
consisted of 130 adolescents: CFS=37; JIA=42; and T1D=52.  
 
Results 
Illness perceptions were found to be significantly different between conditions. 
Adolescents with CFS reported greater perceived consequences, a less chronic timeline 
and lower treatment control than adolescents with JIA or T1D, and less understanding 
of their condition than adolescents with T1D. Adolescents with CFS and JIA reported 
less personal control over their illness than adolescents with T1D. With the exception of 
the consequences subscale, these findings remained consistent when controlling for age, 
gender, fatigue, physical functioning, anxiety and depression.  
 
Implications 
The results from this study provide preliminary evidence supporting the validity 
of the common-sense model in adolescents. This suggests that illness perceptions may 
be important in the assessment, formulation and treatment of adolescents with physical 
health conditions. 
CBT is an evidence-based treatment for CFS. However, CBT requires self-




skills required to bring about change. The findings of lower perceived control in 
adolescents with CFS in this study suggests that psychoeducation, socialisation to the 
model (and its effectiveness) and interventions aimed at improving self-efficacy may be 
important components to be delivered early in CBT for CFS.  
To further our understanding, it would be beneficial for intervention studies for 
CFS to include measures of illness perceptions in order to track changes and their 









Within this connecting narrative, I will reflect on the process of completing my 
main research project, service improvement project, critical review of literature and five 
case studies. I will reflect on some of the challenges I have faced along the way, as well 
as some of the learning I have derived as a result. 
 
Main Research Project 
Study selection and development. At the beginning of the course, at the time 
of project development, I knew I wanted my main research project to be with children 
and young people. However, with no previous experience of working in child services, I 
found difficult to identify specific research gaps to fill. I therefore relied, to an extent, 
on supervisors and other clinicians to provide some potential directions. After a few 
discussions, meetings and initial ideas, Dr Maria Loades introduced me to the area of 
illness perceptions. I was interested by this topic, but it was not something I had prior 
knowledge of. I therefore needed to do extensive reading of relevant literature to 
familiarise myself with the area and develop a meaningful research question, which I 
did in collaboration with Maria. To begin with, I related to my research question in quite 
an academic way. I could see how it contributed to the literature, but I sometimes found 
it harder to see the genuine clinical utility. However, over the course of training I was 
able to consider the research area in relation to the teaching we received and to my 
clinical experiences on placement, which made the research question seem less abstract 
and more clinically meaningful. This has helped me to mentally bridge the gap between 
research and clinical practice. In the future, I hope to be able to develop research 
questions based on gaps evident from clinical practice.  
Ethical approval. I faced several challenges throughout this project. One of the 
main challenges related to the ethics process. I was aware that receiving ethical 
approval for research can be time-intensive and so I worked hard to complete my NHS 
ethics application and submit it as early on in training as I could—just as the second 
year of training began. I found the IRAS ethics application form to be cumbersome and 
the process of completing it made me reflect on how inaccessible it must be for many 
clinicians outside of academia to complete. There seems to be a certain conflict between 
encouragement from Trusts for clinicians to be more involved in research, and the 




application at an early stage, as it meant I had enough time to overcome barriers that 
arose. There is, understandably, extra precaution regarding ethics of research involving 
children. As such, following my research ethics committee panel meeting, it was 
decided that the consent process for my study should be amended so that information 
sheets could be read by potential participants prior to their attendance at the clinical 
appointment where they would be invited to take part. Having made these amendments, 
it later became clear that this was something the hospital was unable to accommodate 
and recruitment was therefore unable to begin. I found this frustrating and I felt 
helpless, as during this period there was very little I could do to move forward with the 
project and there were clinics of potential participants that could not be invited to take 
part in the research because of this barrier. As a result, it was necessary to demonstrate 
to the committee that this requirement was stalling recruitment and to evidence that 
there was similar research operating in the service without this requirement that was 
ethically sound. Eventually, I was granted an amendment that meant sending 
information sheets was not required. This highlighted an advantage of being familiar 
with other local research designs and procedures, but also in being able to use robust 
reasoning to challenge decisions. 
Recruitment and data collection. Once recruitment could begin, it became 
obvious that the two teams I was recruiting from were very different in their set-ups, 
which had a significant bearing on recruitment. Whereas most patients seen in the 
Paediatric Diabetes service have Type 1 Diabetes (and were therefore eligible to 
participate), patients with Juvenile Idiopathic Arthritis are seen under Paediatric 
Rheumatology, which encompasses a wide range of health conditions. It became 
apparent that there was no simple way of identifying eligible participants within the 
Rheumatology service, which posed a real challenge for recruitment. As one of my 
placements was situated in Bristol Children’s Hospital I was able to support this process 
by manually checking clinic lists for eligible participants. However, a further challenge 
was identifying professionals who could invite potential participants to take part. As a 
result, a lot of the data collection was done by myself, which had not been part of the 
original planned procedure. Despite these difficulties, there were several healthcare 
professionals who were very supportive throughout this process and facilitated me being 
able to approach potential participants. 
The recruitment process taught me several things that I will take forward to any 
future involvement in research. For example, I can see how having a physical presence 




been possible otherwise; developing positive relationships with other team members 
was integral to this process. Being embedded in the relevant service therefore seems an 
important factor in the success of recruitment. I can also see the value of developing a 
research contract so that it is clear what the expectations are for all stakeholders and so 
this can be reviewed throughout the research journey. As the practicalities of recruiting 
proved more difficult than was anticipated at the design stage, I can see real value in 
doing a ‘process walkthrough’ where the intricacies of the recruitment process are 
considered. 
Despite the challenges, I found it rewarding to see the project develop from 
conceptualisation, through data collection, analysis and write-up. 
 
Service Improvement Project 
Study selection and development. I initially intended for my Service 
Improvement Project to take place in the service where my first clinical placement was. 
My proposal was approved, but further development and implementation of the project 
proved difficult, not least because the service underwent several big changes and a 
series of team members left the service. I had prioritised my main research project and 
critical review of the literature and so the service improvement project was the last one 
to make headway on. Although I had done a lot of work towards the planning of this 
project, I felt the service context it made it too difficult and too risky to continue with 
the project and I made the decision to take forward a different project instead. At the 
time, I felt worried at having no service improvement project at such a late point in 
training, but I also felt motivated to get stuck into a project and make progress. I 
contacted a field supervisor at Great Western Hospital who shared some initial ideas of 
areas to focus on within the service. The prospect of evaluating supervision groups 
excited me, as it is an area where I was keen to learn more about the evidence base, so I 
was pleased to take on this project. I formed research questions based on the needs of 
the service, but also brought in theoretical underpinnings from wider literature.  
Recruitment and data collection. After developing the design for the project, I 
relied on my field supervisor, Leah, to administer, collect and return questionnaires to 
me to analyse and develop into focus group questions. Her input was also needed to 
support the arrangement of the focus group. I was limited in what I could do from afar, 
so I felt grateful that Leah delivered on what she had agreed to do, especially given how 
busy I know she was. I was aware throughout this project of my position as a trainee 




me about their experiences of having supervision with a clinical psychologist. This was 
thought about carefully and we made several steps along the way to reassure 
participants about the anonymity process. Throughout the focus group, participants 
were very positive about the supervision they received. I found it heartening to hear this 
and it made me reflect on my role as a supervisor in the future. However, I did also have 
initial concerns about how I could use this data to be of help to the service.  
Data analysis. I was glad to have the opportunity to undertake qualitative 
analysis, as this is not something I had not previously done. Through wider reading, I 
came across lots of criticism aimed at the way qualitative research is often conducted. 
This increased my determination to conduct a robust and methodologically sound 
project. However, my lack of experience meant a steep learning curve in the analysis 
process. I found the inherent subjectivity of thematic analysis unsettling and doubted 
my ability to make sense of the data without a framework to follow. The analysis 
process was therefore very time intensive and I developed and changed themes several 
times. I found peer debriefing helpful and reassuring and I could certainly see the value 
of this in increasing ‘trustworthiness’ of the results.  
Conducting this project gave me first-hand experience in some of the advantages 
of using qualitative methodologies. The results included details from participants that it 
would not have been possible to collect with quantitative methodologies only. 
 
Critical Review of Literature 
Study selection and development. I initially found it difficult to identify a 
question for a literature review. Through discussions with Dr Maria Loades, the research 
area of HIV in young people was suggested. This represented an opportunity to learn 
more about an area I had no prior knowledge about. The aspect of the review that 
appealed to me most was the opportunity to be involved in cross-cultural research, with 
the potential to have an impact in an area of the world with limited resources. However, 
this also presented challenges in that I was unfamiliar with the environmental context of 
the research. This made me realise the benefit of personal and professional experience 
for making sense of research findings. Instead, I was reliant on guidance from my 
supervisors and immersing myself in additional literature to meaningfully interpret the 
data (e.g. to identify relevant variables missing from the studies included in the 
literature review).  
Analysis. I was disappointed that so few eligible studies were found for my 




disappointing that authors did not supply relevant data from their datasets when 
contacted. Furthermore, given that several studies focused on the relationship between 
childhood depression and having a family member with HIV, it seemed like an 
oversight not to include childhood HIV status as a variable. 
Despite the fact that so few eligible papers were returned, the systematic review 
ended up being very time-intensive. The nature of the included papers were exploratory, 
cross-sectional designs with high numbers of variables and this provided challenges in 
synthesising the results. It was also necessary to adapt existing quality assessment tools 
to make one appropriate for the type of studies. As I undertook the literature review at 
an early stage in training, I was not able to benefit from peer learning during this 
process and instead felt that I was having to find my own way. This was in contrast to 
my service improvement project, where I felt I was able to benefit from my colleagues’ 
learning experiences of conducting qualitative analyses. 
I found the process of critiquing papers valuable for considering my own 
research, in terms of methodology, analysis and reporting of results.  
 
Case Studies 
Completing case studies on each placement has helped me to link clinical 
practise to theory and has encouraged me to use outcome monitoring. I often found the 
writing-up of case studies a helpful tool for explicitly articulating hypotheses, rather 
than holding them implicitly in mind. Similarly, case studies were an effective prompt 
to consider the reasons for each intervention, for thinking clearly about change 
mechanisms and for monitoring changes.  
 
Overall Reflections 
It has been challenging to juggle so many different research projects alongside 
clinical placement. However, I feel well equipped to conduct research post-qualification 
and hope that being embedded in a service and identifying research gaps through 








I would like to everybody who has supported me over the last three years. I 
would particularly like to thank Dr Maria Loades—my primary supervisor for two 
projects. I am very grateful to Maria for always making herself available to me, for 
always being approachable, and for her (very) timely responses. I am also grateful to 
Maddy, Claire, Sangeeta, Rachel, Kate the physio and the rheumatology nurses for their 
support with data collection. 
Thank you to my parents for their support and encouragement prior to and 
during training. And of course, thanks to Ben for putting up with me, for supporting me, 






APPENDIX A. Quality assessment tools (systematic review) 
Quality assessment tool for assessing studies examining risk factors for depression 
 
Representativeness 
1. What kind of recruitment strategy has been used? 
Randomised/consecutive (2);   Non-randomised/convenience (0);   Not stated (0) 
 
Eligibility Criteria 
2. Have eligibility criteria been specified? 
Yes (1);   No (0) 
 
Sample Size 
3. Is the sample size justified? 
Justified and satisfactory (1)   Not justified (0) 
 
4. What is the sample size? 
≤149 (0);   150-399 (1);   400+ (2) 
 
Participation rate 
5. Is the participation rate reported? 
Reported and over 75% (2);   Reported and under 75% (1);   Not reported (0) 
 
Criteria for Depression 
6. How has depression been detected?  
Clinical interview (2);   Screening tool validated for use in Southern Africa (1);   Other screening tool 
(0) 
 
Criteria for HIV 
7. How has HIV status been ascertained? 
Clinically verified (1);   Self-report, carer-report, or method not reported (0) 
 
Ascertainment of risk factors 
8. Were potential risk factors measured using validated measurements? 
[Not scored, but variables divided into 3 categories: i) using tool validated for use in Southern Africa;   
ii) not validated in South Africa but available or described;   iii) no description of measurement tool] 
 
Confounding factors 
9. Were age, gender and recruitment location controlled for (where appropriate)? 




10.  Were the statistical tests used to analyse the data appropriate and clearly described?  
Data analysis process is well-described, complete, and statistic methods used are robust and appropriate 
(2);   Statistical methods are generally adequate, but some details of data analysis process missing (1);   
Statistical methods are not appropriate, not described or incomplete (0) 
 
Reporting of results 
11. Was the reporting of results complete? 
Reporting of p values, confidence intervals, mean and SD/range for continuous variables (1);   Reporting 
is incomplete (0) 




Quality assessment tool for assessing interventions for depression in HIV-infected youth 
 
Representativeness 
1. What kind of recruitment strategy has been used? 
Randomised/consecutive (2);   Non-randomised/convenience (0);   Not stated (0) 
 
Eligibility Criteria 
2. Have eligibility criteria been specified? 
Yes (1);   No (0) 
 
Sample Size 
3. Is the sample size justified? 
Justified and satisfactory (1)   Not justified (0) 
Participation rate 
4. Is the participation rate reported? 
Reported and over 75% (2);   Reported and under 75% (1);   Not reported (0) 
Criteria for Depression 
5. How has depression been detected?  
Clinical interview (2);   Screening tool validated for use in Southern Africa (1);   Other screening tool (0) 
Criteria for HIV 
6. How has HIV status been ascertained? 
Clinically verified (1);   Self-report, carer-report, or method not reported (0) 
Allocation to condition 
7. Were study participants randomised to intervention/comparison groups? 
Yes (1);   No (0) 
 
Intervention 
8. Was the intervention(s) clearly described? 
Yes (1);   No (0) 
 
Assessment of outcome 
9. Was an attempt made to blind those measuring the main outcome (depression) of the intervention? 
Yes (1);   No (0) 
 
Confounding factors 
10. Were age, gender and recruitment location controlled for (where appropriate)? 
Yes (1);   No (0) 
 
Follow up 
11. Was the follow-up considered? 
Follow-up rates reported (1),   Not (0) 
 
Statistical test: 
12. Were the statistical tests used to analyse the data appropriate and clearly described? 
Test is clearly described and appropriate (2);   Test is acceptable (1);   Test is not appropriate, not described or 
incomplete. (0) 
 
Reporting of results 
13. Was the reporting of results complete? 
Reporting of p values, confidence intervals, mean and SD/range for continuous variables (1);   Reporting is 
incomplete (0) 
Total =       /17
 104 
 
APPENDIX B. Analysis of dataset (systematic review) 
 Provided by (Målqvist et al., 2016). 
 




Scoring 13+ on EDPS 
(n) 
Scoring 13+ 
on EDPS (%) P-value 
Negative 135 13 9.63% 0.007** 
Positive 31 18 58.06%  
 Total 166 31 18.67%   




Analysis for HIV+ participants only: 
 Depressed (n) Non-depressed (n) Total (N) P-value 
Mother's education     
Secondary + 7 10   
Primary 1 1   
None 0 1 20 0.684 
Marital status     
Married / living 3 1   
Single 10 16 30 0.17 
Employment     
Employed 1 1   
Unemployed 11 17 30 0.765 
Housing     
Homestead 5 2   
Tenant 4 11 22 0.047* 
Water source     
Tap 5 13   
Communal 4 5   
Surface 3 0 30 0.058 
Sanitation     
Pit latrine or no toilet 10 16   
Flush toilet 2 2 30 0.661 
Sharing toilet 7 8   
Yes 3 5 23 0.673 
No     
Cut size of meals  3 2   
Yes 10 13 28 0.502 
No     
Not eat for whole day 4 3   
Yes 9 12 28 0.512 
No     
Cut meals for children 3 2   
Yes 10 13 28 0.502 
No     



















Minimum of 4 people 
 
 
1) CASE PRESENTATION 
a) Who is who? 
 
Roles: 
x Facilitator (Fac): Agrees contract/conditions; guides group; focusses discussion and suggestions; 
keeps time; monitors autonomy, respect and receptivity; may consult. 
x Case Presenter (CP): Gives initial Q (no more than 10 words), outlines case with all important 
pieces of information; THE Q; chooses method. 
x CoSupervisors (CoS): Listen (with whole self), self-reflexive and aware; comprehensive questions; 
offer clear and concise ideas/perspectives; work hard with chosen method; support the Fac. 
x Scribe (Sc): The only one with pen and paper. Writes initial Q/THE Q; consulting mode; brief notes 
of suggestions to give to CP; may consult. 
 
1b) How will we work together? (contract) 
Agree on confidentiality, time management, clarity, respect, validity of everyone’s opinion and 
openness (only needs to be done in detail periodically. Just check if anything new should be added at 
start of each session). 
 
1c) What is the work? 
CP starts with the question, which the Sc writes down and places on the table in the middle of the 
group. The CP then offers a 5-7 minute outline.  During this stage no one else speaks.  The Fac listens 
and guides (e.g. lets the presenter know when only 2 minutes left). 
 
 
2) CASE CONSULTATION:  
a) What is THE Question 
The Fac again asks the CP for their key question (this may have changed slightly by this point) and the 
Sc writes it down.  
È 
The Fac asks if anyone in the group has any clarifying questions. 
There should only be a few of these. If there are many, this means the CP needs to give further 
information so the Fac then asks the CP if there is any more information they think the CoS need, and 
take them back to step 2.   
 
2b) How should the group work with this Q? 
The CP picks their method of feedback from the CoS, between the following: 
 
x Sounding board: The CoS share what came up for them as they were listening to the CP (can 
include thoughts, feelings, physical sensations, urges, images, memories etc.). 
x Advice: What the CoS think may be helpful to do in this situation (consider starting sentence with: 









x ‘Show me’: Acting out the particular challenge the CP wants to work on.   
Each CoS ‘role plays’ the conversation with an empty chair, outside of the group: 
 
      .     
 
x Reflecting Team: The CP moves out of the circle and turns his/her back towards the group and then 
the group (CoS) share their reflections about the case.  This discussion should involve anything the 
CoS think is relevant to the key question. 
x Brainstorming: Any ideas about how to move forward, no matter how random. These should be 
short statement, unfiltered and straight to the point. 
x Flip the question:  Changing the question round to the opposite and brainstorming around this.  
 
 
2c) Group work to help the CP with their Q. 
During this stage the CP does not speak and the CoS do not ask questions.   
The consultation should always be conducted with the supervision question in mind. 
The Sc writes down all the points made by the CoS. 
 
 
3) CASE CONCLUSION  
a) Where do you go from here? 
The Sc gives the CP the piece of paper with all the points made by the CoS and the CP shares their 
general feelings about the points made, picking up on the points that resonated the most.  This should 
be done to the group as a whole, not to specific individuals within the group.  The CP then focuses on 
the specific points that they will take forward. 
 
3b) How did I do? 
Feedback to the facilitator (only needs to be done from time to time if it is always the same facilitator). 
 
3c) How did we do? 
Finally, the group reflects on the process as a whole, with particular emphasis on the process and 





APPENDIX D. Ethical approval (SIP) 







Subject: RE: Ethics 17-210
Date: 4 October 2017 at 10:15
To: Cara Haines C.Haines@bath.ac.uk
Cc: Cara Davis C.Davis@bath.ac.uk
Dear Cara,
 
Thank you for taking the time to make these amendments and clarifications. I am happy
to confirm that you have full ethical approval for this amended application. Please use
the code 17-210 as proof of ethical approval on all internal documentation.
 
It’s an interesting point about consent being required for a questionnaire study. I have
gone through the introduction you give and it seems to address the main points we
require from a consent form. As the data will be anonymous it doesn’t fall under the
requirements of the data protection act. I will bring it up at the next committee meeting
for discussion but am happy for you to proceed without written consent in this case.
 
In future please respond within the email chain, as instructed in the email and on the
Psychology moodle page.
 
Best of luck with your research,
Dr. Nathalia Gjersoe
Chair, Psychology Ethics Committee
 
 
From: Cara Haines 
Sent: 03 October 2017 19:49
To: psychology-ethics <psychology-ethics@bath.ac.uk>
Cc: Cara Davis <C.Davis@bath.ac.uk>




Thank you for your response to my application for ethical approval. Please find below
my responses to your points:
 
My understanding of questionnaire research is that completion of a questionnaire
is usually adequate as evidence of consent. In my NHS REC panel for my main
research project this fact was highlighted and they asked me why I had included a
separate consent form for a questionnaire study. This was stated briefly in my
original application form, which I have highlighted for ease of locating. Is this
acceptable according to University of Bath ethics?
The information sheet and consent form for the SIP will indeed be printed on
separate sheets – they were just created on different pages in one Word document
for ease.
The focus group will consist of general questions about the supervision group:
“what is your understanding of supervision in cancer nursing care?”, “how would
you describe the influence of supervision on you over the past six months?”, “how
would you describe the influence that supervision has had on patient care?”. The
latter questions will be based on the responses from the questionnaires and will tap
into how supervision could be improved in these areas. For example, if ratings on
the item  I feel reassured that what I am doing as a professional to support cancer patients is good
From: Nathalia Gjersoe N.Gjersoe@bath.ac.uk
Subject: RE: 17-210: Amendment approved
Date: 6 February 2018 at 09:29
To: Cara Haines C.Haines@bath.ac.uk
Cc: Cara Davis C.Davis@bath.ac.uk
Dear Cara,
 
Thank you for letting us know about this amendment. I am happy to confirm that
you have received full ethical approval, via Chair’s Action. Your file will be
updated to include these changes.
 
Best of luck with your research,
Dr. Nathalia Gjersoe
Chair, Psychology Ethics Committee
 
 
From: Cara Haines 
Sent: 05 February 2018 16:06
To: psychology-ethics <psychology-ethics@bath.ac.uk>
Cc: Nath li  Gjersoe <N.Gjersoe@bath.ac.uk>; Cara Davis <C.Davis@bath.ac.uk>




I am requesting another amendment via chair’s action.
 
I recently received approval for an amendment to allow me to email questionnaires to
nurses, rath r than give paper copies out in person. I am now reques ing further approval
to add in five further questions: one rated question and four optional qualitative
questions. This will allow nurses who did not attend the first focus group to provide in-
depth feedback about the supervision groups if they wish.
 
The additional rated question is as follows:
 
- CNS supervision groups are delivered according to the S.A.C.S model. Below is a
summary of the S.A.C.S model and what should happen in each session. Please rate
supervision over the past 6 months according to how well you think it has adhered to this
model, from 0-10.
1= Supervision foes not adhere to the S.A.C.S model at all
10 = Supervision adheres to the S.A.C.S model completely
 
[I have attached the S.A.C.S model information as it will appear in the questionnaire,
below this question].
 
The further four (optional) qualitative questions are as follows:
 
- What is your understanding of supervision in Cancer Nursing care?
- What do you find most useful about attending the supervision groups?
- How could the supervision groups be improved?
- How could cases be discussed in a way that is more helpful to you?
 




2. Great Western Hospital R&D confirmation 
 
From: TIMBRELLWHITTLE, Beatrice (GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST)
beatrice.timbrellwhittle@nhs.net
Subject: RE: R&D approval for small scale service evaluation
Date: 11 September 2017 at 14:54
To: CALLEBAUT, Leah (GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST) leah.callebaut1@nhs.net
Cc: Cara Haines (C.Haines@bath.ac.uk) C.Haines@bath.ac.uk
Dear Leah,
 
Many thanks for your email.
 
Good news – approval is not necessary for a Quality Improvement project at GWH.
 
However, do keep in touch as we often have celebratory events and we would love to have you
involved at our next event.
 







Quality Improvement Project Lead








From: CALLEBAUT, Leah (GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST) 
Sent: 06 September 2017 11:35
To: TIMBRELLWHITTLE, Beatrice (GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST)
Cc: Cara Haines (C.Haines@bath.ac.uk)




I have been passed your details by the R&D team following my query below….
 
R&D have suggested that they don’t need to give approval for this service
evaluation/improvement project to take place as it is not a piece of research. However they
suggested I seek approval from the quality improvement team for the trainee working with me
to be on site at GWH – I would appreciate it if you could advise me further e.g. if any
paperwork needs to be completed etc. The trainee psychologist completing the work is
employed by another NHS Trust but not GWH so I wasn’t sure if an honorary contact would
be needed?
 




APPENDIX E. Adapted evaluation questionnaire (SIP) 
 (original available from British Psychological Society, 2015) 
 
Please consider your experience of the supervision group over the last six months and 
rate each question using the scale below:  
1 2 3 4 5 
 
Not at all    Yes, definitely 
 
Question Rating 
I felt that this group is a safe space to reflect, ask questions, share my ideas and 
experiences   
 
I felt supported by other people in the group  
When I shared something with the group I felt heard by them    
I felt that other group members treated my contribution with respect when I shared 
something with them   
 
I have felt reassured that what I am doing as a professional to support cancer patients is 
good enough 
 
I feel that the way cases are discussed in this group is helpful for me    
By attending the group, I have considered how I look after myself  
I have regularly shared or addressed issues relevant to working with cancer patients   
I have come away from the group understanding a bit more about the experience and 
needs of a person with cancer 
 
As a result of attending the group I understand more about responding to patient distress   
I have learnt something useful about how to deal with challenging situations with my 
patients and their families 
 
 
Overall, how confident do you feel about discussing psychological problems with your patients with 
cancer? 
10 9 8 7 6 5 4 3 2 1 
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South West - Frenchay Research Ethics Committee 
Level 3, Block B 
Whitefriars 
Lewins Mead, 










01 July 2016 
 
Dr Maria Loades 






Dear Dr Loades  
 
Study title: Depression in Paediatric Chronic Fatigue Syndrome (CFS/ME) 
REC reference: 16/SW/0136 
IRAS project ID: 203495 
 
Thank you for your submission of 29th June 2016, responding to the Committee’s request for 
further information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair. 
 
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the 
date of this opinion letter. Should you wish to provide a substitute contact point, require further 
information, or wish to make a request to postpone publication, please contact the REC 
Manager, Miss Natasha Bridgeman, nrescommittee.southwest-frenchay@nhs.net. 
 
 
Confirmation of ethical opinion 
 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation 
as revised, subject to the conditions specified below. 
 
 
Conditions of the favourable opinion 
 
The REC favourable opinion is subject to the following conditions being met prior to the start of 
Please note: This is the favourable opinion 
of the REC only and does not allow you to 
start your study at NHS sites in England 












Management permission must be obtained from each host organisation prior to the start of the 
study at the site concerned. 
 
Management permission should be sought from all NHS organisations involved in the study in 
accordance with NHS research governance arrangements. Each NHS organisation must 
confirm through the signing of agreements and/or other documents that it has given permission 
for the research to proceed (except where explicitly specified otherwise).  
Guidance on applying for NHS permission for research is available in the Integrated Research 
Application System, www.hra.nhs.uk or at http://www.rdforum.nhs.uk.   
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites ("participant identification centre"), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation.  
 
Sponsors are not required to notify the Committee of management permissions from host 
organisations 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered 
on a publically accessible database within 6 weeks of recruitment of the first participant (for 
medical device studies, within the timeline determined by the current registration and publication 
trees).   
 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment.  We will audit the registration details as part of 
the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered but 
for non-clinical trials this is not currently mandatory. 
 
If a sponsor wishes to contest the need for registration they should contact Catherine Blewett 
(catherineblewett@nhs.net), the HRA does not, however, expect exceptions to be made. 
Guidance on where to register is provided within IRAS.  
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable). 
 




The favourable opinion applies to all NHS sites taking part in the study, subject to management 














The final list of documents reviewed and approved by the Committee is as follows: 
Document   Version   Date   
Covering letter on headed paper [Cover Letter ref 203495]  1  14 April 2016  
Covering letter on headed paper [Cover Letter ref 203495]  1  27 May 2016  
Evidence of Sponsor insurance or indemnity (non NHS Sponsors only) 
[Insurance Confirmation ref 203495]  
1  12 April 2016  
GP/consultant information sheets or letters [Info for healthcare 
professionals ref 203495]  
1  12 April 2016  
Interview schedules or topic guides for participants [Safety Plan 
Agreement Form]  
1  12 April 2016  
Interview schedules or topic guides for participants [K-SADS PL 5 2013]      
Interview schedules or topic guides for participants [Sections of KSADS 
used in study]  
    
Interview schedules or topic guides for participants [Sections of KSADS 
used in study]  
2  27 May 2016  
IRAS Application Form [IRAS_Form_20042016]    20 April 2016  
IRAS Checklist XML [Checklist_29062016]    29 June 2016  
Letters of invitation to participant [Consent to contact form ref 203495]  1  12 April 2016  
Other [Debrief sheet]  1  12 April 2016  
Participant consent form [Participant Consent Form 16+]  3  29 June 2016  
Participant consent form [Participant Consent Form &lt; 16s]  3  29 June 2016  
Participant consent form [Participant Consent Form Parents]  3  29 June 2016  
Participant information sheet (PIS) [Participant Information Sheet ref 
203495]  
3  24 June 2016  
Research protocol or project proposal [Paediatric CFS &amp; 
Depression study protocol]  
3  24 June 2016  
Summary CV for Chief Investigator (CI) [Maria's Brief CV]  1  12 April 2016  
Summary CV for student [Rebecca Read (RA) CV]  1  03 June 2016  
Summary CV for student [Sarah Stoll (RA) CV]  1  03 June 2016  
Summary CV for student [Soraya S (RA) CV]  1  03 June 2016  
Summary CV for supervisor (student research) [Esther Crawley CV ref 
203495]  
1  12 April 2016  
Validated questionnaire [Clinical Assessment Pack]      
Validated questionnaire [Postal Questionnaire Pack for pre clinical 
assessment]  
    
Validated questionnaire [Postal assessment pack for over 12s - 
completed pre-clinical assessment]  
    
Validated questionnaire [RCADS Self-report]      
Validated questionnaire [RCADS Parent Report]      
Validated questionnaire [Brief Illness Perceptions Questionnaire]      
Validated questionnaire [Brief Illness Perceptions Questionnaire Parent 
Version]  










Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK. 
 




The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
x Notifying substantial amendments 
x Adding new sites and investigators 
x Notification of serious breaches of the protocol 
x Progress and safety reports 
x Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light of 





The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received and 
the application procedure. If you wish to make your views known please use the feedback form 
available on the HRA website: 




We are pleased to welcome researchers and R&D staff at our training days – see details at 

























16/SW/0136                          Please quote this number on all correspondence 
 










Enclosures:  “After ethical review – guidance for 
   researchers”  
 
Copy to: Dr  Birgit  Whitman 
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Dr Maria Loades 







08 August 2016 
 
Dear Dr Loades,    
 
 
Study title: Depression in Paediatric Chronic Fatigue Syndrome 
(CFS/ME) 
IRAS project ID: 203495  
REC reference: 16/SW/0136   
Sponsor University of Bristol 
 
I am pleased to confirm that HRA Approval has been given for the above referenced study, on the 
basis described in the application form, protocol, supporting documentation and any clarifications 
noted in this letter.  
 
Participation of NHS Organisations in England  
The sponsor should now provide a copy of this letter to all participating NHS organisations in England.  
 
Appendix B provides important information for sponsors and participating NHS organisations in 
England for arranging and confirming capacity and capability. Please read Appendix B carefully, in 
particular the following sections: 
x Participating NHS organisations in England – this clarifies the types of participating 
organisations in the study and whether or not all organisations will be undertaking the same 
activities 
x Confirmation of capacity and capability - this confirms whether or not each type of participating 
NHS organisation in England is expected to give formal confirmation of capacity and capability. 
Where formal confirmation is not expected, the section also provides details on the time limit 
given to participating organisations to opt out of the study, or request additional time, before 
their participation is assumed. 
x Allocation of responsibilities and rights are agreed and documented (4.1 of HRA assessment 
criteria) - this provides detail on the form of agreement to be used in the study to confirm 
capacity and capability, where applicable. 
Further information on funding, HR processes, and compliance with HRA criteria and standards is also 
provided. 
 
It is critical that you involve both the research management function (e.g. R&D office) supporting each 
organisation and the local research team (where there is one) in setting up your study. Contact details 
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and further information about working with the research management function for each organisation 
can be accessed from www.hra.nhs.uk/hra-approval.  
 
Appendices 
The HRA Approval letter contains the following appendices: 
x A – List of documents reviewed during HRA assessment 
x B – Summary of HRA assessment 
 
After HRA Approval 
The document “After Ethical Review – guidance for sponsors and investigators”, issued with your REC 
favourable opinion, gives detailed guidance on reporting expectations for studies, including:  
x Registration of research 
x Notifying amendments 
x Notifying the end of the study 
The HRA website also provides guidance on these topics, and is updated in the light of changes in 
reporting expectations or procedures. 
 
In addition to the guidance in the above, please note the following: 
x HRA Approval applies for the duration of your REC favourable opinion, unless otherwise 
notified in writing by the HRA. 
x Substantial amendments should be submitted directly to the Research Ethics Committee, as 
detailed in the After Ethical Review document. Non-substantial amendments should be 
submitted for review by the HRA using the form provided on the HRA website, and emailed to 
hra.amendments@nhs.net.  
x The HRA will categorise amendments (substantial and non-substantial) and issue confirmation 
of continued HRA Approval. Further details can be found on the HRA website. 
 
Scope  
HRA Approval provides an approval for research involving patients or staff in NHS organisations in 
England.  
 
If your study involves NHS organisations in other countries in the UK, please contact the relevant 
national coordinating functions for support and advice. Further information can be found at 
http://www.hra.nhs.uk/resources/applying-for-reviews/nhs-hsc-rd-review/. 
  
If there are participating non-NHS organisations, local agreement should be obtained in accordance 
with the procedures of the local participating non-NHS organisation. 
 
User Feedback 
The Health Research Authority is continually striving to provide a high quality service to all applicants 
and sponsors. You are invited to give your view of the service you have received and the application 
procedure. If you wish to make your views known please email the HRA at hra.approval@nhs.net. 
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We are pleased to welcome researchers and research management staff at our training days – see 
details at http://www.hra.nhs.uk/hra-training/  
 











Copy to: Dr Birgit Whitman, University of Bristol, Sponsor Contact 
birgit.whitman@bristol.ac.uk 
 
 Jane Carter, Royal National Hospital for Rheumatic Diseases NHS Foundation 
Trust, Lead NHS R&D Contact 
ruh-tr.RNHRDresearch@nhs.net 
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Appendix A - List of Documents 
 
The final document set assessed and approved by HRA Approval is listed below.   
 
 Document   Version   Date   
Covering letter on headed paper [Cover Letter ref 203495]  1  14 April 2016  
Covering letter on headed paper [Cover Letter ref 203495]  1  27 May 2016  
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [University of Bristol confirmation of insurance]  
 4 August 2016  
GP/consultant information sheets or letters [Info for healthcare 
professionals ref 203495]  
1  12 April 2016  
Interview schedules or topic guides for participants [Safety Plan 
Agreement Form]  
1  12 April 2016  
Interview schedules or topic guides for participants [K-SADS PL 5 
2013]  
    
Interview schedules or topic guides for participants [Sections of 
KSADS used in study]  
    
Interview schedules or topic guides for participants [Sections of 
KSADS used in study]  
2  27 May 2016  
IRAS Application Form [IRAS_Form_20042016]    20 April 2016  
Letters of invitation to participant [Consent to contact form ref 
203495]  
1  12 April 2016  
Other [Debrief sheet]  1  12 April 2016  
Other [Schedule of Events]  2  27 July 2016  
Other [Statement of Actvities ]  2  27 July 2016  
Other [Notice of non-substantial amendment]  27 July 2016 
Participant consent form [Under 16s]  4  27 July 2016  
Participant consent form [Over 16s ]  4  27 July 2016  
Participant consent form [Parent ]  4  27 July 2016  
Participant information sheet (PIS) [PIS parent and child]  4  27 July 2016  
Research protocol or project proposal [Paediatric CFS &amp; 
Depression study protocol]  
3  24 June 2016  
Summary CV for Chief Investigator (CI) [Maria's Brief CV]  1  12 April 2016  
Summary CV for student [Rebecca Read (RA) CV]  1  03 June 2016  
Summary CV for student [Sarah Stoll (RA) CV]  1  03 June 2016  
Summary CV for student [Soraya S (RA) CV]  1  03 June 2016  
Summary CV for supervisor (student research) [Esther Crawley CV 
ref 203495]  
1  12 April 2016  
Validated questionnaire [Clinical Assessment Pack]      
Validated questionnaire [Postal Questionnaire Pack for pre clinical 
assessment]  
    
Validated questionnaire [Postal assessment pack for over 12s - 
completed pre-clinical assessment]  
    
Validated questionnaire [RCADS Self-report]      
Validated questionnaire [RCADS Parent Report]      
Validated questionnaire [Brief Illness Perceptions Questionnaire]      
Validated questionnaire [Brief Illness Perceptions Questionnaire 
Parent Version]  
2  27 May 2016  
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Appendix B - Summary of HRA Assessment 
 
This appendix provides assurance to you, the sponsor and the NHS in England that the study, as 
reviewed for HRA Approval, is compliant with relevant standards. It also provides information and 
clarification, where appropriate, to participating NHS organisations in England to assist in assessing 
and arranging capacity and capability. 
For information on how the sponsor should be working with participating NHS organisations in 
England, please refer to the, participating NHS organisations, capacity and capability and 
Allocation of responsibilities and rights are agreed and documented (4.1 of HRA assessment 
criteria) sections in this appendix.  
The following person is the sponsor contact for the purpose of addressing participating organisation 
questions relating to the study: 
 
Birgit Whitman (0117 331 7130, birgit.whitman@bristol.ac.uk)  
 
HRA assessment criteria  
Section HRA Assessment Criteria Compliant with 
Standards 
Comments 
1.1 IRAS application completed 
correctly 
Yes No comments 
 
    
2.1 Participant information/consent 
documents and consent 
process 
Yes A non-substantial amendment was 
submitted following REC approval to 
update consent documentation to bring 
it in line with HRA standards  
    
3.1 Protocol assessment 
 
Yes No comments 
 
    
4.1 Allocation of responsibilities 
and rights are agreed and 
documented  
Yes A statement of activities has been 
submitted to act as agreement between 






Yes Where applicable, independent 
contractors (e.g. General Practitioners) 
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Section HRA Assessment Criteria Compliant with 
Standards 
Comments 
indemnity provided by their medical 
defence organisation covers the 
activities expected of them for this 
research study 
4.3 Financial arrangements 
assessed  
Yes The statement of activities confirms no 
funding will be provided by the sponsor 
to sites. 
The applicant has confirmed that an 
application for funding from the NIHR 
for doctoral fellowship is in progress. 
The applicant has confirmed that the 
study will proceed even if the funding 
application is not secured.  
 
    
5.1 Compliance with the Data 
Protection Act and data 
security issues assessed 
Yes No comments 
 
5.2 CTIMPS – Arrangements for 
compliance with the Clinical 
Trials Regulations assessed 
Not Applicable No comments 
 
5.3 Compliance with any 
applicable laws or regulations 
Yes No comments  
    
6.1 NHS Research Ethics 
Committee favourable opinion 





6.2 CTIMPS – Clinical Trials 
Authorisation (CTA) letter 
received 
Not Applicable No comments 
 
6.3 Devices – MHRA notice of no 
objection received 
Not Applicable No comments 
 
6.4 Other regulatory approvals 
and authorisations received 
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Participating NHS Organisations in England 
This provides detail on the types of participating NHS organisations in the study and a statement as to whether 
the activities at all organisations are the same or different.  
There is one site type for this study; all sites will undertake the same activities.  
 
The Chief Investigator or sponsor should share relevant study documents with participating NHS 
organisations in England in order to put arrangements in place to deliver the study. The documents 
should be sent to both the local study team, where applicable, and the office providing the research 
management function at the participating organisation. For NIHR CRN Portfolio studies, the Local 
LCRN contact should also be copied into this correspondence.  For further guidance on working with 
participating NHS organisations please see the HRA website. 
 
If chief investigators, sponsors or principal investigators are asked to complete site level forms for 
participating NHS organisations in England which are not provided in IRAS or on the HRA website, 
the chief investigator, sponsor or principal investigator should notify the HRA immediately at 
hra.approval@nhs.net. The HRA will work with these organisations to achieve a consistent approach 
to information provision.  
 
Confirmation of Capacity and Capability  
This describes whether formal confirmation of capacity and capability is expected from participating NHS 
organisations in England. 
Participating NHS organisations in England will be expected to formally confirm their capacity 
and capability to host this research.  
x Following issue of this letter, participating NHS organisations in England may now confirm to 
the sponsor their capacity and capability to host this research, when ready to do so. How 
capacity and capacity will be confirmed is detailed in the Allocation of responsibilities and 
rights are agreed and documented (4.1 of HRA assessment criteria) section of this appendix.  
x The Assessing, Arranging, and Confirming document on the HRA website provides further 
information for the sponsor and NHS organisations on assessing, arranging and confirming 
capacity and capability. 
 
 
Principal Investigator Suitability 
This confirms whether the sponsor position on whether a PI, LC or neither should be in place is correct for each 
type of participating NHS organisation in England and the minimum expectations for education, training and 
experience that PIs should meet (where applicable). 
A local collaborator would be expected at sites where access for external staff may need to be 
facilitated.  
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HR Good Practice Resource Pack Expectations 
This confirms the HR Good Practice Resource Pack expectations for the study and the pre-engagement checks 
that should and should not be undertaken 
Letters of Access will be expected if any external staff, without an existing contractual relationship in 
place, will access the site. Sites to confirm the necessary DBS and Occupational Health checks have 
been completed. 
 
Other Information to Aid Study Set-up  
This details any other information that may be helpful to sponsors and participating NHS organisations in 
England to aid study set-up. 












Dr Michael J Proulx 
Chair, Psychology Ethics Committee 
Telephone +44 01225 385963 





Department of Psychology 
 




18th July 2016 
 
Dear Dr. Maria Loades 
 
Reference number 16-203: Depression in Paediatric Chronic Fatigue Syndrome 
 
I am writing to confirm that the Psychology Ethics Committee has provided full ethical approval for 
the above project, as decided by Dr Ailsa Russell via Chair’s Action. 
 
Best wishes with your research. 
 
Dr Michael J Proulx 









Gwasanaeth Moeseg Ymchwil 





Wales REC 3 
 Health and Care Research Wales Castlebridge 4  
15 – 19 Cowbridge Road East  
Cardiff   CF11 9AB  
Telephone : 029 2078 5735      
 
E-mail : corinne.scott@wales.nhs.uk 









27 January 2017 
 
 Miss Cara Haines 
Trainee Clinical Psychologist 
Taunton and Somerset NHS Foundation Trust 
10W, Department of Psychology 
University of Bath 
Claverton 
Bath   BA2 7AY 
 
 
Dear Miss Haines  
 
Study title: Illness perceptions in young people with long term conditions 
REC reference: 16/WA/0378 
Protocol number: N/A 
IRAS project ID: 212752 
 
Thank you for responding to the Committee’s request for further information on the above research 
and submitting revised documentation. 
 
The further information was considered by a Sub-Committee of the REC at a meeting held on 27 
January 2017.    A list of the Sub-Committee members is attached.   
 
We plan to publish your research summary wording for the above study on the HRA website, together 
with your contact details. Publication will be no earlier than three months from the date of this opinion 
letter.  Should you wish to provide a substitute contact point, require further information, or wish to 
make a request to postpone publication, please contact hra.studyregistration@nhs.net outlining the 
reasons for your request. 
 
Confirmation of ethical opinion 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation as 
revised, subject to the conditions specified below. 
 
Conditions of the favourable opinion 
The REC favourable opinion is subject to the following conditions being met prior to the start of the 
study. 
 
Management permission must be obtained from each host organisation prior to the start of the study 
at the site concerned. 
 
Management permission should be sought from all NHS organisations involved in the study in 
accordance with NHS research governance arrangements. Each NHS organisation must confirm 
Please note:  This is the favourable opinion of the 
REC only and does not allow you to start your study at NHS 









through the signing of agreements and/or other documents that it has given permission for the 
research to proceed (except where explicitly specified otherwise).  
Guidance on applying for NHS permission for research is available in the Integrated Research 
Application System, www.hra.nhs.uk or at http://www.rdforum.nhs.uk.   
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites ("participant identification centre"), guidance should be sought from the 
R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation.  
 
Sponsors are not required to notify the Committee of management permissions from host 
organisations 
 
Registration of Clinical Trials 
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered on a 
publically accessible database within 6 weeks of recruitment of the first participant (for medical device 
studies, within the timeline determined by the current registration and publication trees).   
 
There is no requirement to separately notify the REC but you should do so at the earliest opportunity 
e.g. when submitting an amendment.  We will audit the registration details as part of the annual 
progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered but for 
non-clinical trials this is not currently mandatory. 
 
If a sponsor wishes to request a deferral for study registration within the required timeframe, they 
should contact hra.studyregistration@nhs.net. The expectation is that all clinical trials will be 
registered, however, in exceptional circumstances non registration may be permissible with prior 
agreement from the HRA. Guidance on where to register is provided on the HRA website.   
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with before 
the start of the study or its initiation at a particular site (as applicable). 
 
Ethical review of research sites 
NHS sites 
The favourable opinion applies to all NHS sites taking part in the study, subject to management 
permission being obtained from the NHS/HSC R&D office prior to the start of the study (see 
"Conditions of the favourable opinion" below). 
 
Approved documents 
The final list of documents reviewed and approved by the Committee is as follows: 
 
Document   Version   Date   
Covering letter on headed paper [Cover letter outlining 
amendments]  
Version 1  08 January 2017  
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Insurance documents]  
2  10 October 2016  
IRAS Application Form [IRAS_Form_10112016]    10 November 2016  
IRAS Checklist XML [Checklist_10112016]    10 November 2016  
IRAS Checklist XML [Checklist_08012017]    08 January 2017  
IRAS Checklist XML [Checklist_11012017]    11 January 2017  
Letter from sponsor [Sponsorship Approval]  1  09 November 2016  
Other [Schedule of events]    18 November 2016  
Other [Statement of Activities]    18 November 2016  
Other [Participant debrief sheet]  Version 2  07 January 2017  
Other [Assent question screenshot]  Version 1  07 January 2017  








Participant information sheet (PIS) [Parent/carer info sheet for 11-15 
year olds (online)]  
V1  19 September 2016  
Participant information sheet (PIS) [Amended PIS age 16-17]  Version 2 
(without track 
changes)  
07 January 2017  
Participant information sheet (PIS) [PIS 11-15 print version]  V2  07 January 2017  
Participant information sheet (PIS) [PIS 16-17 track changes]  V2  07 January 2017  
Participant information sheet (PIS) [PIS 11-15 track changes print 
version]  
V2  07 January 2017  
Research protocol or project proposal [Amended protocol/proposal]  Version 2 
(with track 
changes)  
08 January 2017  
Summary CV for Chief Investigator (CI) [Cara brief CV]  1  18 September 2016  
Summary CV for student [Madeline CV]  1  18 September 2016  
Summary CV for supervisor (student research) [Maria brief CV]  1  18 September 2016  
Summary CV for supervisor (student research) [Cara Davis CV]  1  18 September 2016  
Validated questionnaire [BIPQ]  V1  19 September 2016  
Validated questionnaire [RCADS]  V1  19 September 2016  
Validated questionnaire [chalder fatigue scale (CFQ)]  V1  19 September 2016  
Validated questionnaire [SF-36 physical functioning subscale]  V1  19 September 2016  
 
Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangements for Research Ethics 
Committees and complies fully with the Standard Operating Procedures for Research Ethics 
Committees in the UK. 
 
After ethical review 
Reporting requirements 
The attached document “After ethical review – guidance for researchers” gives detailed guidance on 
reporting requirements for studies with a favourable opinion, including: 
 
x Notifying substantial amendments 
x Adding new sites and investigators 
x Notification of serious breaches of the protocol 
x Progress and safety reports 
x Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light of changes in 
reporting requirements or procedures. 
 
User Feedback 
The Health Research Authority is continually striving to provide a high quality service to all applicants 
and sponsors. You are invited to give your view of the service you have received and the application 
procedure. If you wish to make your views known please use the feedback form available on the HRA 
website: http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/    
 
HRA Training 
We are pleased to welcome researchers and R&D staff at our training days – see details at 
http://www.hra.nhs.uk/hra-training/   
 














Dr. Corinne Scott 
Senior Ethics Service Manager 
Health and Care Research Wales  
 





Enclosures:  List of names and professions of members who were present at the meeting  
and those who submitted written comments  
   “After ethical review – guidance for researchers” 
 
Copy to: Professor Jonathan Knight 
 Rachel Brophy, University Hospitals Bristol NHS Foundation Trust 
 
 
   
 
 
Wales REC 3 
 
Attendance at Sub-Committee of the REC meeting on 27 January 2017 
 
  
Committee Members:  
 
Name   Profession   Present    Notes   
Mrs  Monika Hare  Vice Chair / Lay member  Yes  Chaired meeting 
Dr Richard Walker  Alternate Vice Chair / 
Lay Plus member  
Yes     
Mr Stewart Williams  Lay Plus member  Yes     
  
Also in attendance:  
 
Name   Position (or reason for attending)   
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Wales REC 3 
Health and Care Research Wales Support Centre 
Castlebridge 4 
15-19 Cowbridge Road East 
Cardiff    CF11 9AB 
 
Telephone : 029 2078 5741      
E-mail : helen.williams19@wales.nhs.uk 
Website : www.hra.nhs.uk      
 
 
29 August 2017 
 
Miss Cara Haines 
Trainee Clinical Psychologist 
Taunton and Somerset NHS Foundation Trust 
10W, Department of Psychology 





Dear Miss Haines 
 
Study title: Illness perceptions in young people with long term conditions 
REC reference: 16/WA/0378  
Protocol number: N/A  
Amendment number: 1 
Amendment date: 20 August 2017 
IRAS project ID: 212752 
 
Thank you for submitting the above amendment, which was received on 24 August 2017. I can 
confirm that this is a valid notice of a substantial amendment and will be reviewed by the Committee at 
its next meeting on 14 September 2017. 
 
Documents received 
The documents to be reviewed are as follows: 
 
Document   Version   Date   
Covering letter on headed paper  Signed by Cara 
Haines  
18 August 2017  
Notice of Substantial Amendment (non-CTIMP)  1  20 August 2017  
Research protocol or project proposal  3 (tracked changes)  25 August 2017  
Research protocol or project proposal  3 (clean)  25 August 2017  
 
 
The Committee will issue an ethical opinion on the amendment within a maximum of 35 days from the 
date of receipt. 
 
All investigators and research collaborators in the NHS should notify the R&D office for the relevant 
NHS care organisation of this amendment and check whether it affects R&D approval for the research. 
 
We are pleased to welcome researchers and R & D staff at our Research Ethics Service Committee 












Mrs Helen Williams 
Health and Care Research Wales  
Research Ethics Committee Co-ordinator 
 
Email - helen.williams19@wales.nhs.uk 
 
 
Copy to: Rachel Brophy, University Hospitals Bristol NHS Foundation Trust 
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Miss Cara Haines 
Trainee Clinical Psychologist 
Taunton and Somerset NHS Foundation Trust 
10W, Department of Psychology 






08 February 2017 
 
Dear Miss Haines     
 
 
Study title: Illness perceptions in young people with long term 
conditions 
IRAS project ID: 212752  
Protocol number: N/A 
REC reference: 16/WA/0378   
Sponsor University of Bath 
 
I am pleased to confirm that HRA Approval has been given for the above referenced study, on the 
basis described in the application form, protocol, supporting documentation and any clarifications 
noted in this letter.  
 
Participation of NHS Organisations in England  
The sponsor should now provide a copy of this letter to all participating NHS organisations in England.  
 
Appendix B provides important information for sponsors and participating NHS organisations in 
England for arranging and confirming capacity and capability. Please read Appendix B carefully, in 
particular the following sections: 
x Participating NHS organisations in England – this clarifies the types of participating 
organisations in the study and whether or not all organisations will be undertaking the same 
activities 
x Confirmation of capacity and capability - this confirms whether or not each type of participating 
NHS organisation in England is expected to give formal confirmation of capacity and capability. 
Where formal confirmation is not expected, the section also provides details on the time limit 
given to participating organisations to opt out of the study, or request additional time, before 
their participation is assumed. 
x Allocation of responsibilities and rights are agreed and documented (4.1 of HRA assessment 
criteria) - this provides detail on the form of agreement to be used in the study to confirm 
capacity and capability, where applicable. 
Further information on funding, HR processes, and compliance with HRA criteria and standards is also 
provided. 
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It is critical that you involve both the research management function (e.g. R&D office) supporting each 
organisation and the local research team (where there is one) in setting up your study. Contact details 
and further information about working with the research management function for each organisation 
can be accessed from www.hra.nhs.uk/hra-approval.  
 
Appendices 
The HRA Approval letter contains the following appendices: 
x A – List of documents reviewed during HRA assessment 
x B – Summary of HRA assessment 
 
After HRA Approval 
The document “After Ethical Review – guidance for sponsors and investigators”, issued with your REC 
favourable opinion, gives detailed guidance on reporting expectations for studies, including:  
x Registration of research 
x Notifying amendments 
x Notifying the end of the study 
The HRA website also provides guidance on these topics, and is updated in the light of changes in 
reporting expectations or procedures. 
 
In addition to the guidance in the above, please note the following: 
x HRA Approval applies for the duration of your REC favourable opinion, unless otherwise 
notified in writing by the HRA. 
x Substantial amendments should be submitted directly to the Research Ethics Committee, as 
detailed in the After Ethical Review document. Non-substantial amendments should be 
submitted for review by the HRA using the form provided on the HRA website, and emailed to 
hra.amendments@nhs.net.  
x The HRA will categorise amendments (substantial and non-substantial) and issue confirmation 
of continued HRA Approval. Further details can be found on the HRA website. 
 
Scope  
HRA Approval provides an approval for research involving patients or staff in NHS organisations in 
England.  
 
If your study involves NHS organisations in other countries in the UK, please contact the relevant 
national coordinating functions for support and advice. Further information can be found at 
http://www.hra.nhs.uk/resources/applying-for-reviews/nhs-hsc-rd-review/. 
  
If there are participating non-NHS organisations, local agreement should be obtained in accordance 










IRAS project ID 212752 
 
Page 3 of 8 
 
User Feedback 
The Health Research Authority is continually striving to provide a high quality service to all applicants 
and sponsors. You are invited to give your view of the service you have received and the application 
procedure. If you wish to make your views known please email the HRA at hra.approval@nhs.net. 
Additionally, one of our staff would be happy to call and discuss your experience of HRA Approval.  
 
HRA Training 
We are pleased to welcome researchers and research management staff at our training days – see 
details at http://www.hra.nhs.uk/hra-training/  
 











Copy to: Professor Jonathan Knight, University of Bath, (Sponsor Contact) 
Ms Rachel Brophy, University Hospitals Bristol NHS Foundation Trust,  
(Lead NHS R&D Contact) 
   
 











IRAS project ID 212752 
 
Page 4 of 8 
 
Appendix A - List of Documents 
 
The final document set assessed and approved by HRA Approval is listed below.   
 
Document   Version   Date   
Covering letter on headed paper [Cover letter outlining 
amendments]  
Version 1  08 January 2017  
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Insurance documents]  
2  10 October 2016  
IRAS Application Form [IRAS_Form_10112016]    10 November 2016  
IRAS Checklist XML [Checklist_11012017]    11 January 2017  
Letter from sponsor [Sponsorship Approval]  1  09 November 2016  
Other [Schedule of events]  1  08 February 2017  
Other [Statement of Activities]  1  08 February 2017  
Other [Participant debrief sheet]  Version 2  07 January 2017  
Other [Assent question screenshot]  Version 1  07 January 2017  
Other [Sponsor Confirmation of non-substantial amendments]    23 February 2017  
Participant consent form [9_2_17 consent form]  2  09 February 2017  
Participant information sheet (PIS) [9_2_17 PIS 16to17]  3  09 February 2017  
Participant information sheet (PIS) [9_2_17 PIS 11to15]  3  09 February 2017  
Research protocol or project proposal [Amended protocol/proposal]  Version 2 
(with track 
changes)  
08 January 2017  
Summary CV for Chief Investigator (CI) [Cara brief CV]  1  18 September 2016  
Summary CV for student [Madeline CV]  1  18 September 2016  
Summary CV for supervisor (student research) [Maria brief CV]  1  18 September 2016  
Summary CV for supervisor (student research) [Cara Davis CV]  1  18 September 2016  
Validated questionnaire [BIPQ]  V1  19 September 2016  
Validated questionnaire [RCADS]  V1  19 September 2016  
Validated questionnaire [chalder fatigue scale (CFQ)]  V1  19 September 2016  
Validated questionnaire [SF-36 physical functioning subscale]  V1  19 September 2016  
 







IRAS project ID 212752 
 
Page 5 of 8 
 
Appendix B - Summary of HRA Assessment 
 
This appendix provides assurance to you, the sponsor and the NHS in England that the study, as 
reviewed for HRA Approval, is compliant with relevant standards. It also provides information and 
clarification, where appropriate, to participating NHS organisations in England to assist in assessing 
and arranging capacity and capability. 
For information on how the sponsor should be working with participating NHS organisations in 
England, please refer to the, participating NHS organisations, capacity and capability and 
Allocation of responsibilities and rights are agreed and documented (4.1 of HRA assessment 
criteria) sections in this appendix.  
The following person is the sponsor contact for the purpose of addressing participating organisation 
questions relating to the study: 
 
Name: Professor Jonathan Knight  
Tel: 01225383162 
Email: pro-vc-research@bath.ac.uk  
 
HRA assessment criteria  
Section HRA Assessment Criteria Compliant with 
Standards 
Comments 
1.1 IRAS application completed 
correctly 
Yes No comments  
    
2.1 Participant information/consent 
documents and consent 
process 
Yes No comments 
    
3.1 Protocol assessment Yes No comments 
    
4.1 Allocation of responsibilities 
and rights are agreed and 
documented  
Yes The sponsor has submitted the HRA 
Statement of Activities and intends for 
this to form the agreement between the 
sponsor and study sites.  
 
The sponsor is not requesting, and 
does not require any additional 
contracts with study sites. 
4.2 Insurance/indemnity Yes Where applicable, independent 
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Section HRA Assessment Criteria Compliant with 
Standards 
Comments 
arrangements assessed should ensure that the professional 
indemnity provided by their medical 
defence organisation covers the 
activities expected of them for this 
research study 
4.3 Financial arrangements 
assessed  
Yes No application for external funding has 
been made. 
    
5.1 Compliance with the Data 
Protection Act and data 
security issues assessed 
Yes No comments 
5.2 CTIMPS – Arrangements for 
compliance with the Clinical 
Trials Regulations assessed 
Not Applicable No comments 
5.3 Compliance with any 
applicable laws or regulations 
Yes No comments 
    
6.1 NHS Research Ethics 
Committee favourable opinion 
received for applicable studies 
Yes 
 
REC Favourable Opinion was issued by 
the Wales Research Ethics Committee 
3 on the 27th January 2017.  
Amended documents were submitted 
on by the researchers to comply with 
HRA Approval standards. These were 
classified by the sponsor as a non-
substantial amendment.  
6.2 CTIMPS – Clinical Trials 
Authorisation (CTA) letter 
received 
Not Applicable No comments 
6.3 Devices – MHRA notice of no 
objection received 
Not Applicable No comments 
6.4 Other regulatory approvals 
and authorisations received 
Not Applicable No comments 
 
  
Participating NHS Organisations in England 
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the activities at all organisations are the same or different.  
All participating NHS organisations will undertake the same study activities. There is therefore only 
one study site ‘type’ involved in the research.  
 
The Chief Investigator or sponsor should share relevant study documents with participating NHS 
organisations in England in order to put arrangements in place to deliver the study. The documents 
should be sent to both the local study team, where applicable, and the office providing the research 
management function at the participating organisation. For NIHR CRN Portfolio studies, the Local 
LCRN contact should also be copied into this correspondence.  For further guidance on working with 
participating NHS organisations please see the HRA website. 
 
If chief investigators, sponsors or principal investigators are asked to complete site level forms for 
participating NHS organisations in England which are not provided in IRAS or on the HRA website, 
the chief investigator, sponsor or principal investigator should notify the HRA immediately at 
hra.approval@nhs.net. The HRA will work with these organisations to achieve a consistent approach 
to information provision. 
 
Confirmation of Capacity and Capability 
This describes whether formal confirmation of capacity and capability is expected from participating NHS 
organisations in England. 
NHS organisations in England that are participating in the study will be expected to formally 
confirm their capacity and capability to host this research.   
x Following issue of this letter, participating NHS organisations in England may now confirm to 
the sponsor their capacity and capability to host this research, when ready to do so. How 
capacity and capacity will be confirmed is detailed in the Allocation of responsibilities and 
rights are agreed and documented (4.1 of HRA assessment criteria) section of this appendix.  
x The Assessing, Arranging, and Confirming document on the HRA website provides further 
information for the sponsor and NHS organisations on assessing, arranging and confirming 
capacity and capability. 
 
Principal Investigator Suitability 
This confirms whether the sponsor position on whether a PI, LC or neither should be in place is correct for each 
type of participating NHS organisation in England and the minimum expectations for education, training and 
experience that PIs should meet (where applicable). 
A Local Collaborator should be appointed at study sites.  
 
GCP training is not a generic training expectation, in line with the HRA statement on training 
expectations. 
 
HR Good Practice Resource Pack Expectations 
This confirms the HR Good Practice Resource Pack expectations for the study and the pre-engagement checks 
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If members of the external research team will be attending NHS sites to conduct the study activities 
detailed at IRAS SA18 and A19 they should obtain a Letter of Access. This would be on the basis of 
a Research Passport or an NHS to NHS confirmation of pre-engagement checks letter (if NHS 
employed). Pre-engagement checks should confirm standard DBS checks and occupational health 
clearance.  
 
Other Information to Aid Study Set-up  
This details any other information that may be helpful to sponsors and participating NHS organisations in 
England to aid study set-up. 











Date: 10 February 2017 at 18:25
To: Cara Haines C.Haines@bath.ac.uk
Dear Cara,
 
Thank you very much for completing the application and including the relevant
documents. Following approval from the NHS REC panel, I am happy to confirm that
you have full ethical approval from Bath University via Chair’s Action. Please use the
code 17-019 as your ethics code for any internal requirements.
 
Best of luck with your data collection,
 
Dr. Nathalia Gjersoe
Chair, Psychology Ethics Committee
From: Cara Haines 
Sent: 10 February 2017 13:01





Please find attached my application for University ethical approval for my main research
project, to be reviewed via chair’s action. 
 
I have attached the letter of favourable opinion from the NHS REC panel that reviewed
it, as well as the Participant Information Sheets, consent form, debrief sheet and
questionnaires.
 

















Subject: RE: Amendment request 17-019.
Date: 26 July 2017 at 10:02
To: Cara Haines C.Haines@bath.ac.uk, psychology-ethics psychology-ethics@bath.ac.uk
Dear Cara,
 
Thank you for letting us know about this amendment. I am happy to confirm that
you have received full ethical approval, via Chair’s Action. Your file will be
updated to include these changes. Please be aware that university specifications
for safe storage of personal human data require that data files be kept encrypted
as well as password protected (in this instance the consent forms). Please be
aware of these specifications and implement in your data storage plan:
http://www.bath.ac.uk/data-protection/guidance/academic-research/index.html
 
Best of luck with your research,
Dr. Nathalia Gjersoe





From: Cara Haines 
Sent: 24 July 2017 11:14
To: psychology-ethics <psychology-ethics@bath.ac.uk>
Cc: Nathalia Gjersoe <N.Gjersoe@bath.ac.uk>




My project has already been approved by the University of Bath (ethics code 17-
019) and has full NHS ethical approval. I would like to request an amendment in
order to additionally recruit non-NHS participants online. This amendment is
therefore being requested from the University of Bath ethics board only, and not
NHS ethics. From my understanding of the online guidance, this can be
considered under the Chair's Action. Please let me know if this is not the case.
 
Due to my project having been granted NHS ethics, my previous University of
Bath ethics application did not contain answers for questions 2-18. Please find
attached a more detailed ethical application form. I have highlighted in yellow the












APPENDIX G. Statistical power calculations (MRP) 
 
Although Moss-Morris and Chalder (2003) compared illness perceptions 
between individuals with CFS and rheumatoid arthritis, they used the IPQ-R rather than 
the BIPQ, meaning effect sizes are unlikely to be directly comparable. 
The brief-IPQ was used in a recent study comparing illness perceptions in CFS 
patients and non-CFS fatigued patients (De Gucht et al., 2016). Significant between-
group differences were found on four variables. Sample size required to detect these 
differences are outlined in Table 5, based on the data reported in the study. With equal 
sample sizes, a sample of 37 in each group would be large enough to detect differences 
on ¾ of the variables. 
 















required for each 
group (equal sizes) 
Overall sample 
size N2/N1 = 3 
Consequence 6.93 8.5 1.73 1.57 37 98 
Timeline 5.39 7.57 1.99 1.95 28 74 
Treatment 
control 
3.44 4.47 2.56 2.58 195 520 
Identity 5.33 7.41 2.24 2.08 36 94 







APPENDIX H. Supplementary analysis (MRP) 
Analysis of illness perceptions in depressed vs non-depressed participants 
 
Background 
CFS has a high comorbidity with depression; it is estimated that 29% of young 
people with CFS also have depression and this is associated with disease severity 
(Bould, Collin, Lewis, Rimes, & Crawley, 2013). Beck’s (1979) cognitive theory of 
depression outlines that depressed individuals have negatively biased cognitions, which 
maintains the depression. According to the CSM, such negative cognitions may form 
part of an individual’s psychological context, which feeds into the cognitive perceptions 
held about illness, as well as the coping strategies utilised (Leventhal, Weinman, 
Leventhal, & Phillips, 2008). The CSM also proposes that emotional reactions to illness 
(including feelings of depression) are processed in parallel to cognitive perceptions 
(Diefenbach & Leventhal, 1996); these emotional perceptions influence coping and 
outcomes, which in turn feed back into cognitive perceptions. In line with this, 
depression in adults has been associated with more negative illness perceptions in a 
number of physical health conditions (Grace et al., 2005; Murphy, Dickens, Creed, & 
Bernstein, 1999; Philip, Lindner, & Lederman, 2009). To date, no studies have looked at 
the relationship between depression and illness perceptions in young people with CFS.  
 
Method  
Gender, grade and raw scores for RCADS depression subscale can be used to 
generate t-scores (Chorpita, Ebesutani, & Spence, 2015). A t-score of ≥70 indicates 
clinical threshold for ‘probable depression’ has been met and was used to divide 
participants into ‘depressed’ and ‘non-depressed’ subgroups. Participant age was used to 
infer grade. To compare depressed and non-depressed participants, a series of Mann-
Whitney tests were conducted using BIPQ subscales as the dependent variable and 
binary depression variable (depressed vs. non-depressed) as the independent variable. 
Holm-Bonferroni correction was used for multiple comparisons. 
 
Results 
Comparisons found that depressed participants’ ratings were significantly higher 
on consequences, identity and emotional response subscales compared with non-
depressed participants. Depressed participants rated their personal control significantly 




Table 6. Comparison of depressed and non-depressed participants in BIPQ subscales  
 Depressed 
N = 43 




N = 87 




Consequences 7.44 (1.76) 6.03 (2.12) <.001* 
Timeline 7.98 (2.35) 7.78 (2.48) .682 
Personal control 3.60 (2.35) 4.84 (2.29) .007* 
Treatment control 6.12 (2.79) 7.33 (2.36) .018 
Identity 7.02 (2.25) 5.91 (2.14) .001* 
Concern 6.28 (2.89) 5.31 (2.39) .032 
Understanding 7.26 (2.53) 7.82 (2.03) .304 
Emotional response 7.70 (1.97) 5.62 (2.85) <.001* 
 *significant using Holm-Bonferroni adjust p-values 
 
 
